AGREEMENT AND PLAN OF MERGER dated as of June 29, 2003 by and among INFORMATION RESOURCES, INC., GINGKO CORPORATION and GINGKO ACQUISITION CORP.
QuickLinks -- Click here to rapidly navigate through this document
ExhibitΒ 99(d)(1)
dated as of
JuneΒ 29, 2003
by and
among
INFORMATION RESOURCES,Β INC.,
GINGKO CORPORATION
and
GINGKO ACQUISITION CORP.
Β |
Β | Β |
Β | Page |
---|---|---|---|---|
ARTICLE I THE OFFER |
||||
Section 1.01. |
Β |
The Offer |
Β |
2 |
Section 1.02. | Β | Company Actions | Β | 3 |
Section 1.03. | Β | Directors of the Company | Β | 4 |
Section 1.04. | Β | Top-Up Option | Β | 5 |
ARTICLE II THE MERGER |
||||
Section 2.01. |
Β |
The Merger |
Β |
7 |
Section 2.02. | Β | Closing | Β | 7 |
Section 2.03. | Β | Effective Time | Β | 7 |
Section 2.04. | Β | Effects of the Merger | Β | 8 |
Section 2.05. | Β | Certificate of Incorporation and By-Laws | Β | 8 |
Section 2.06. | Β | Directors | Β | 8 |
Section 2.07. | Β | Officers | Β | 8 |
Section 2.08. | Β | Effect on Capital Stock | Β | 8 |
Section 2.09. | Β | Exchange of Certificates | Β | 9 |
Section 2.10. | Β | Options | Β | 11 |
Section 2.11. | Β | Restricted Stock | Β | 11 |
ARTICLE III REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB |
||||
Section 3.01. |
Β |
Organization and Qualification |
Β |
12 |
Section 3.02. | Β | Authority; Non-Contravention; Approvals | Β | 12 |
Section 3.03. | Β | Interim Operations of Merger Sub | Β | 13 |
Section 3.04. | Β | Capital Resources | Β | 13 |
Section 3.05. | Β | Offer Documents; Proxy Statement | Β | 14 |
Section 3.06. | Β | Interest in the Company | Β | 14 |
Section 3.07. | Β | Brokers and Finders | Β | 14 |
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY |
||||
Section 4.01. |
Β |
Organization and Qualification |
Β |
15 |
Section 4.02. | Β | Capitalization | Β | 15 |
Section 4.03. | Β | Subsidiaries | Β | 17 |
Section 4.04. | Β | Authority; Non-Contravention; Approvals | Β | 18 |
Section 4.05. | Β | Reports and Financial Statements | Β | 20 |
Section 4.06. | Β | Absence of Undisclosed Liabilities | Β | 20 |
Section 4.07. | Β | Absence of Certain Changes or Events | Β | 20 |
Β | Β | Β | Β | Β |
i
Section 4.08. | Β | Litigation | Β | 21 |
Section 4.09. | Β | Offer Documents; Proxy Statement | Β | 21 |
Section 4.10. | Β | No Violation of Law | Β | 22 |
Section 4.11. | Β | Material Contracts; Compliance With Agreements | Β | 22 |
Section 4.12. | Β | Taxes | Β | 23 |
Section 4.13. | Β | Employee Benefit Plans; ERISA | Β | 24 |
Section 4.14. | Β | Labor Controversies | Β | 26 |
Section 4.15. | Β | Environmental Matters | Β | 27 |
Section 4.16. | Β | Intellectual Property | Β | 28 |
Section 4.17. | Β | Opinion of Financial Advisor | Β | 29 |
Section 4.18. | Β | Brokers and Finders | Β | 29 |
Section 4.19. | Β | Insurance | Β | 29 |
Section 4.20. | Β | Takeover Statutes | Β | 29 |
Section 4.21. | Β | Receivables and Customers | Β | 29 |
ARTICLE V COVENANTS |
||||
Section 5.01. |
Β |
Conduct of Business Pending the Merger |
Β |
30 |
Section 5.02. | Β | Restrictions on Parent and the Company | Β | 32 |
Section 5.03. | Β | No Solicitation | Β | 33 |
Section 5.04. | Β | Access to Information; Confidentiality | Β | 34 |
Section 5.05. | Β | Merger Sub | Β | 35 |
Section 5.06. | Β | Employee Benefits | Β | 35 |
Section 5.07. | Β | Proxy Statement | Β | 37 |
Section 5.08. | Β | Company Meeting | Β | 37 |
Section 5.09. | Β | Public Announcements | Β | 38 |
Section 5.10. | Β | Expenses and Fees | Β | 38 |
Section 5.11. | Β | Agreement to Cooperate | Β | 38 |
Section 5.12. | Β | Directors' and Officers' Indemnification | Β | 39 |
Section 5.13. | Β | Section 16 Matters | Β | 40 |
Section 5.14. | Β | Further Assurances | Β | 40 |
Section 5.15. | Β | Notices of Certain Events | Β | 41 |
ARTICLE VI CONDITIONS TO THE MERGER |
||||
Section 6.01. |
Β |
Conditions to the Obligations to Consummate the Merger |
Β |
42 |
ARTICLE VII TERMINATION |
||||
Section 7.01. |
Β |
Termination |
Β |
42 |
Β | Β | Β | Β | Β |
ii
ARTICLE VIII MISCELLANEOUS |
||||
Section 8.01. |
Β |
Effect of Termination |
Β |
44 |
Section 8.02. | Β | Non-Survival of Representations and Warranties | Β | 45 |
Section 8.03. | Β | Notices | Β | 46 |
Section 8.04. | Β | Interpretation | Β | 47 |
Section 8.05. | Β | Miscellaneous | Β | 47 |
Section 8.06. | Β | Counterparts | Β | 48 |
Section 8.07. | Β | Amendments; Extensions | Β | 48 |
Section 8.08. | Β | Entire Agreement | Β | 48 |
Section 8.09. | Β | Severability | Β | 49 |
Section 8.10. | Β | Specific Performance; Limitation on Damages | Β | 49 |
Section 8.11. | Β | No Admission | Β | 49 |
Section 8.12. | Β | Jurisdiction | Β | 49 |
Section 8.13. | Β | WAIVER OF JURY TRIAL | Β | 49 |
iii
Β Β Β Β Β Β Β Β AGREEMENT AND PLAN OF MERGER, dated as of JuneΒ 29, 2003 (as the same may be amended from time to time and together with the schedules, exhibits and annexes attached hereto, this "Agreement"), by and among Gingko Corporation, a Delaware corporation (together with its successors and permitted assigns, "Parent"), Gingko Acquisition Corp., a Delaware corporation and wholly-owned Subsidiary (as defined in SectionΒ 3.02 of this Agreement) of Parent (together with its successors and permitted assigns, "Merger Sub"), and Information Resources,Β Inc., a Delaware corporation (the "Company").
RECITALS
Β Β Β Β Β Β Β Β WHEREAS, the respective boards of directors of each of Parent, Merger Sub and the Company have determined that it is in the best interests of their respective stockholders for Merger Sub to acquire the Company on the terms and subject to the conditions set forth in this Agreement;
Β Β Β Β Β Β Β Β WHEREAS, in furtherance thereof, Parent and Merger Sub shall make a tender offer (as it may be amended from time to time as permitted under this Agreement, and together with the tender offer made during any "subsequent offering period" (as provided by RuleΒ 14d-11 under the Securities Exchange Act of 1934, as amended, together with the rules and regulations thereunder (collectively, the "Exchange Act")), the "Offer") to purchase all of the outstanding shares of common stock, par value $0.01, of the Company, together with the associated Company Rights (as defined herein) (the "Company Common Stock"), at a purchase price per share of the Company Common Stock of one CVR (as defined below) and $3.30 per share (the CVR and such price per share or any greater amount paid per share of Company Common Stock pursuant to the Offer is herein referred to as the "Offer Price"), net to each seller in cash, without interest, on the terms and subject to the conditions set forth in this Agreement;
Β Β Β Β Β Β Β Β WHEREAS, the respective boards of directors of each of Parent, Merger Sub and the Company have approved and declared advisable the Offer, this Agreement and the merger of Merger Sub with and into the Company (the "Merger") following the consummation of the Offer, on the terms and subject to the conditions set forth in this Agreement, whereby each issued share of the Company Common Stock not owned by Parent, Merger Sub or the Company, other than the Appraisal Shares (as defined herein), shall be converted pursuant to the Merger into the right to receive the Merger Consideration (as defined herein);
Β Β Β Β Β Β Β Β WHEREAS, the Company, Parent and Merger Sub propose to enter into a Contingent Value Rights Agreement (as the same may be amended from time to time and together with any schedules, exhibits and annexes attached thereto, the "CVR Agreement") with the Rights Agents (as defined therein) prior to the Acceptance Date (as defined herein) pursuant to which, Parent will issue the CVRs (as defined herein) as part of the Offer Price pursuant to the Offer or as a part of the Merger Consideration pursuant to the Merger; and
Β Β Β Β Β Β Β Β WHEREAS, the Company, Parent and Merger Sub desire to make certain representations, warranties, covenants and agreements pursuant to this Agreement.
Β Β Β Β Β Β Β Β NOW, THEREFORE, in consideration of the foregoing and the respective representations, warranties, covenants and agreements set forth in this Agreement and intending to be legally bound hereby, the parties hereto hereby agree as follows:
ARTICLE I
THE OFFER
Β Β Β Β Β Β Β Β SectionΒ 1.01.Β Β Β Β The Offer.Β Β Β Β (a)Β Subject to the conditions of this Agreement and provided that this Agreement shall not have been terminated in accordance with its terms pursuant to ArticleΒ VII hereof and none of the events set forth in paragraphs (a)Β through (f)Β of ExhibitΒ A hereto shall have occurred or be existing, as promptly as reasonably practicable but in no event later than ten business days after the date of the public announcement of this Agreement, Parent and Merger Sub shall commence the Offer within the meaning of the applicable rules and regulations of the Securities and Exchange Commission (the "SEC"). The obligations of Parent and Merger Sub to accept for payment, and pay for, any shares of Company Common Stock tendered pursuant to the Offer are subject to the conditions set forth in ExhibitΒ A. The initial expiration date of the Offer shall be the 20th business day following the commencement of the Offer (the initial "Expiration Date," and any expiration time and date established pursuant to an authorized extension of the Offer as so extended, shall also be defined herein as an "Expiration Date"). Parent and Merger Sub expressly reserve the right to waive any condition to the Offer or modify the terms of the Offer, except that, without the written consent of the Company, Merger Sub shall not (i)Β reduce the number of shares of Company Common Stock subject to the Offer, (ii)Β reduce the Offer Price to be paid pursuant to the Offer, (iii)Β change or waive the Minimum Tender Condition (as defined in ExhibitΒ A), add to the conditions set forth in ExhibitΒ Aor modify any condition set forth in ExhibitΒ A in any manner adverse to the holders of Company Common Stock, (iv)Β except as provided below in this SectionΒ 1.01(a), extend the Offer, (v)Β change the form of consideration payable in the Offer or (vi)Β otherwise amend the Offer in any manner adverse to the holders of Company Common Stock. Notwithstanding the foregoing, Merger Sub may (but shall not be obligated to), without the consent of the Company and in its sole and absolute discretion, (A)Β from time to time extend the Offer if, at the scheduled Expiration Date, any of the conditions of the Offer shall not have been satisfied or waived until such time as such conditions are satisfied or waived to the extent permitted by this Agreement; (B)Β extend the Offer for any period required by any rule, regulation, interpretation or position of the SEC applicable to the Offer; or (C)Β extend the Offer for a "subsequent offering period" (as provided by RuleΒ 14d-11 under the Exchange Act) for a period of three to twenty business days in order to acquire at least 90% of the outstanding shares of the Company Common Stock. On the terms and subject to the conditions to the Offer that are set forth in this Agreement, promptly after the Expiration Date, either Parent or Merger Sub shall accept for payment and purchase, as promptly as practicable after the date on which Parent or Merger Sub (as the case may be) first accepts shares for payment pursuant to the Offer (the "Acceptance Date"), all shares of Company Common Stock validly tendered and not withdrawn pursuant to the Offer that Parent and Merger Sub are permitted to accept and pay for under applicable law.
2
Β Β Β Β Β Β Β Β (b)Β Β Β On the date of commencement of the Offer, Parent and Merger Sub shall file with the SEC, and cause to be disseminated to the Company's stockholders, as and to the extent required by applicable federal securities laws, a Tender Offer Statement on Schedule TO with respect to the Offer, which shall contain an offer to purchase and a related letter of transmittal and summary advertisement (such Schedule TO and the documents included therein pursuant to which the Offer will be made, together with any supplements or amendments thereto, the "Offer Documents"). Each of Parent, Merger Sub and the Company shall promptly correct any information provided by it for use in the Offer Documents if and to the extent that such information shall have originally been or shall become false or misleading in any material respect (whether by virtue of a material misstatement, material omission or otherwise), and each of Parent and Merger Sub shall take all steps necessary to amend or supplement the Offer Documents and to cause the Offer Documents as so amended or supplemented to be filed with the SEC and the Offer Documents as so amended or supplemented to be disseminated to the Company's stockholders, in each case as and to the extent required by or deemed advisable under applicable federal securities laws. The Company and its counsel shall be given reasonable opportunity to review and comment upon the Offer Documents prior to their filing with the SEC or dissemination to the stockholders of the Company. Parent and Merger Sub shall provide to the Company and its counsel in writing any written comments (and orally, any oral comments), Parent, Merger Sub or their counsel may receive from the SEC or its staff with respect to the Offer Documents promptly after the receipt of such comments and shall consult with the Company and its counsel prior to responding to any such comments.
Β Β Β Β Β Β Β Β (c)Β Β Β Parent shall provide or cause to be provided to Merger Sub on a timely basis the funds necessary to purchase any shares of Company Common Stock that Merger Sub becomes obligated to purchase pursuant to the Offer.
Β Β Β Β Β Β Β Β SectionΒ 1.02.Β Β Β Β Company Actions.Β Β Β Β (a)Β The Company hereby approves of and consents to the Offer, the Merger and the other transactions contemplated by this Agreement. The Company hereby consents to the inclusion in the Offer Documents of the recommendation of the Company's board of directors described in SectionΒ 4.04(d).
Β Β Β Β Β Β Β Β (b)Β Β Β Subject to SectionΒ 5.03, on the date the Offer Documents are filed with the SEC, the Company shall file with the SEC a Solicitation/Recommendation Statement on ScheduleΒ 14D-9 with respect to the Offer (such ScheduleΒ 14D-9, as amended or supplemented from time to time, and together with the information required to be provided by SectionΒ 14(f) of the Exchange Act and RuleΒ 14f-1 promulgated thereunder, the "ScheduleΒ 14D-9") containing the recommendations referred to in SectionΒ 4.04(d) and shall mail the ScheduleΒ 14D-9 to the holders of Company Common Stock. Each of the Company, Parent and Merger Sub shall promptly correct any information provided by it for use in the ScheduleΒ 14D-9 if and to the extent that such information shall have originally been or shall have become false or misleading in any material respect, (whether by virtue of a material misstatement, material omission or otherwise), and the Company shall take all steps necessary to amend or supplement the ScheduleΒ 14D-9 and to cause the ScheduleΒ 14D-9 as so amended or supplemented to be filed with the SEC and disseminated to the Company's stockholders, in each case as and to the extent required by or deemed advisable under applicable federal securities laws. Parent and its counsel shall be given reasonable opportunity to review and comment upon the ScheduleΒ 14D-9 prior to its filing with the SEC or dissemination to stockholders of the Company. The Company shall provide Parent
3
and its counsel in writing with any written comments (and orally, any oral comments) the Company or its counsel may receive from the SEC or its staff with respect to the ScheduleΒ 14D-9 promptly after the receipt of such comments and shall consult with Parent and its counsel prior to responding to such comments and shall give due regard to any comments made by such parties.
Β Β Β Β Β Β Β Β (c)Β Β Β In connection with the Offer and the Merger, the Company shall cause its transfer agent to furnish Merger Sub promptly with mailing labels containing the names and addresses of the record holders of Company Common Stock as of a recent date and of those persons becoming record holders subsequent to such date, together with copies of all lists of stockholders, security position listings and computer files and all other information in the Company's possession or control regarding the beneficial owners of Company Common Stock, and shall furnish to Merger Sub such information and assistance (including updated lists of stockholders, security position listings and computer files) as Parent may reasonably request in communicating the Offer to the Company's stockholders. Subject to the requirements of applicable law, and except for such steps as are necessary to disseminate the Offer Documents and any other documents necessary to consummate the Offer, the Merger and the other transactions contemplated by this Agreement, Parent and Merger Sub shall hold in confidence the information contained in any such labels, listings and files, shall use such information only in connection with the Offer and the Merger and, if this Agreement shall be terminated, shall, upon request, deliver to the Company all copies of such information then in their possession.
Β Β Β Β Β Β Β Β SectionΒ 1.03.Β Β Β Β Directors of the Company.Β Β Β Β (a)Β Upon the Acceptance Date, Parent shall be entitled to designate such number of directors, rounded up to the next whole number, on the Board of Directors of the Company as is equal to the product obtained by multiplying the total number of directors on such Board (giving effect to the directors designated by Parent pursuant to this sentence) by the percentage that the number of shares of Company Common Stock purchased and paid for by Parent or Merger Sub pursuant to the Offer, plus any shares beneficially owned by Parent or its affiliates on the date of such purchase and payment, bears to the total number of shares of Company Common Stock then outstanding. On the expiration of any subsequent offering period (as provided by RuleΒ 14d-11 under the Exchange Act), Parent shall be entitled to designate such number of directors, rounded up to the next whole number, on the Board of Directors of the Company as is equal to the product obtained by multiplying the total number of directors on such Board (giving effect to the directors designated by Parent pursuant to this and the immediately preceding sentence) by the percentage that the number of shares of Company Common Stock purchased and paid for by Parent or Merger Sub pursuant to the Offer (including, but not limited to, the number of shares purchased in any subsequent offering period), plus any shares beneficially owned by Parent or its Affiliates on the date of such purchase and payment in the subsequent offering period, bears to the total number of shares of Company Common Stock then outstanding. In furtherance of the rights and obligations set forth in the immediately foregoing two sentences, the Company shall, upon request of Parent, promptly increase the size of its Board of Directors, or it shall secure the resignations of such number of directors, or both, as is necessary to enable Parent's designees to be so elected to the Company's Board and, subject to SectionΒ 14(f) of the Exchange Act and RuleΒ 14f-1 promulgated thereunder, shall cause Parent's designees to be so elected. At such time, the Company shall, if requested by Parent, also cause directors designated by Parent to constitute at least the same percentage (rounded up to the next whole number) as is on the Company's Board of Directors of each committee of the Company's Board of Directors. Notwithstanding the foregoing, if shares
4
of Company Common Stock are purchased pursuant to the Offer, there shall be until the Effective Time at least two members of the Company's Board of Directors who are directors on the date hereof and are not employees of the Company.
Β Β Β Β Β Β Β Β (b)Β Β Β The Company shall promptly take all actions required pursuant to SectionΒ 14(f) of the Exchange Act and RuleΒ 14f-1 promulgated thereunder in order to fulfill its obligations under SectionΒ 1.03(a), including mailing to stockholders together with the ScheduleΒ 14D-9 the information required by such SectionΒ 14(f) and RuleΒ 14f-1 as is necessary to enable Parent's designees to be elected to the Company's Board of Directors. Parent and Merger Sub will supply the Company and be solely responsible for any information with respect to them and their nominees, officers, directors and affiliates required by such SectionΒ 14(f) and RuleΒ 14f-1.
Β Β Β Β Β Β Β Β (c)Β Β Β Following the election of Parent's designees to the Company's Board of Directors pursuant to this SectionΒ 1.03, prior to the Effective Time (i)Β any amendment or termination of this Agreement by the Company, (ii)Β any extension or waiver by the Company of the time for the performance of any of the obligations or other acts of Parent or Merger Sub under this Agreement, or (iii)Β any waiver of any of the Company's rights hereunder shall, in any such case, require the concurrence of a majority of the directors of the Company then in office who neither were designated by Parent nor are employees of the Company (the "Independent Director Approval").
Β Β Β Β Β Β Β Β SectionΒ 1.04.Β Β Β Β Top-Up Option.Β Β Β Β (a)Β Subject to the terms and conditions herein, the Company hereby grants to Parent an irrevocable option (the "Top-Up Option") to purchase up to that number of shares of Company Common Stock (the "Top-Up Option Shares") equal to the lowest number of shares of Company Common Stock that, when added to the number of shares of Company Common Stock collectively owned by Parent, Merger Sub and any of their respective Affiliates immediately following consummation of the Offer, shall constitute at least 90Β percent of the shares of Company Common Stock then outstanding on a fully diluted basis (assuming the issuance of the Top-Up Option Shares and the exercise of all Company Options (as defined herein) and any other rights to acquire Company Common Stock on the date of the Top-Up Exercise Event (as defined below)) at a purchase price per Top-Up Option Share equal to the Offer Price.
Β Β Β Β Β Β Β Β (b)Β Β Β Parent may, at its election, exercise the Top-Up Option, in whole, but not in part, at any one time after the occurrence of a Top-Up Exercise Event and prior to the occurrence of a Top-Up Termination Event (as defined below).
Β Β Β Β Β Β Β Β A "Top-Up Exercise Event" shall occur upon Parent's or Merger Sub's acceptance for payment pursuant to the Offer (which shall include, for sake of clarity, any subsequent offering period that Parent or Merger Sub may elect to extend pursuant to the terms and conditions of this Agreement) of shares of Company Common Stock constituting, together with Company Common Stock owned directly or indirectly by any other Affiliates of Parent, less than 90Β percent of the shares of the Company Common Stock then outstanding on a fully diluted basis (assuming the exercise of all Company Options (as defined herein) and any other rights to acquire Company Common Stock on the date of the Top-Up Exercise Event), but only if (i)Β the issuance of the Top-Up Option Shares pursuant thereto would not require the approval of the stockholders of the Company under applicable law or regulation (including, but not limited to,
5
NASDAQ rules and regulations, including SectionΒ 4350(i)1(D) of the NASD Manual) or (ii)Β NASDAQ has granted a waiver from any such rule or regulation that is reasonably acceptable to the parties hereto, and there is no other applicable law, rule or regulation that would require the approval of the Company's stockholders for the issuance of the Top-Up Shares. Upon and after the request of Parent, the Company will use its reasonable best efforts (but without the payment of any money) to obtain such a waiver from NASDAQ as promptly as possible after any such request.
Β Β Β Β Β Β Β Β The "Top-Up Termination Date" shall occur upon the earliest to occur of (i)Β the Effective Time, (ii)Β the termination of this Agreement, (iii)Β the date that is ten business days after the occurrence of a Top-Up Exercise Event, unless the Top-Up Option has been previously exercised in accordance with the terms and conditions hereof and (iv)Β the date that is ten business days after the Top-Up Notice Date unless the Top-Up Closing shall have previously occurred.
Β Β Β Β Β Β Β Β (c)Β Β Β If Parent wishes to exercise the Top-Up Option, Parent shall send to the Company a written notice (a "Top-Up Exercise Notice", and the date of receipt of which notice is referred to herein as the "Top-Up Notice Date") specifying the place for the closing of the purchase and sale of shares of Company Common Stock pursuant to the Top-Up Option (the "Top-Up Closing") and a date not earlier than one business day nor later than ten business days after the Top-Up Notice Date for the Top-Up Closing. The Company shall, promptly after receipt of the Top-Up Exercise Notice, deliver a written notice to Parent confirming the number of Top-Up Option Shares and the aggregate purchase price therefor.
Β Β Β Β Β Β Β Β (d)Β Β Β At the Top-Up Closing, subject to the terms and conditions of this Agreement, (i)Β the Company shall deliver to Parent a certificate or certificates evidencing the applicable number of Top-Up Option Shares; provided that the obligation of the Company to deliver Top-Up Option Shares upon the exercise of the Top-Up Option is subject to the condition that no provision of any applicable law or regulation and no judgment, injunction, order or decree shall prohibit the exercise of the Top-Up Option or the delivery of the Top-Up Option Shares in respect of any such exercise and (ii)Β Parent shall purchase each Top-Up Option Share from the Company at the Offer Price. Payment by Parent of the purchase price for the Top-Up Option Shares may be made, at Parent's option, by delivery of (i)Β immediately available funds by wire transfer to an account designated by the Company or (ii)Β a demand note issued by Parent in customary form that is reasonably acceptable to the parties and in a principal face amount equal to the aggregate amount of the cash portion of the purchase price for the Top-Up Option Shares, together with, in case of both clauses (i)Β and (ii)Β above, that number of CVRs equal to the number of Top-Up Option Shares to be issued pursuant to the exercise of the Top Up Option. Any demand note issued pursuant to the preceding sentence shall be accompanied by a credit support arrangement reasonably acceptable to the parties hereto.
Β Β Β Β Β Β Β Β (e)Β Β Β Upon the delivery by Parent to the Company of the Top-Up Exercise Notice, and the tender of the consideration described in SectionΒ 1.04(d), Parent shall be deemed to be the holder of record of the Top-Up Option Shares issuable upon that exercise, notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing those Top-Up Option Shares shall not then be actually delivered to
6
Parent or the Company shall have failed or refused to designate the bank account described in SectionΒ 1.04(d).
Β Β Β Β Β Β Β Β (f)Β Β Β Β Parent shall pay all expenses, and any and all federal, state and local taxes and other charges, that may be payable in connection with the preparation, issuance and delivery of stock certificates under this SectionΒ 1.04.
Β Β Β Β Β Β Β Β (g)Β Β Β Certificates evidencing Top-Up Option Shares delivered hereunder may include legends legally required including a legend in substantially the following form:
THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY BE REOFFERED OR SOLD ONLY IF SO REGISTERED OR IF AN EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.
ARTICLE II
THE MERGER
Β Β Β Β Β Β Β Β SectionΒ 2.01.Β Β Β Β The Merger.Β Β Β Β After the Expiration Date, upon the terms and subject to the conditions set forth in this Agreement, and in accordance with the Delaware General Corporation Law (the "DGCL"), Merger Sub shall be merged with and into the Company at the Effective Time (as defined in SectionΒ 2.03). At the Effective Time, the separate corporate existence of Merger Sub shall cease and the Company shall continue as the surviving corporation (the "Surviving Corporation") and shall succeed to and assume all of the rights and obligations of Merger Sub in accordance with the DGCL.
Β Β Β Β Β Β Β Β SectionΒ 2.02.Β Β Β Β Closing.Β Β Β Β Upon the terms and subject to the conditions set forth in this Agreement, the closing of the Merger (the "Closing") shall take place at 10:00Β a.m., New York time, on the second business day after the satisfaction or (to the extent permitted by applicable law and this Agreement) waiver of the conditions set forth in ArticleΒ VII (other than those conditions to be satisfied or waived at the Closing), at the offices of Xxxxx XxxxΒ & Xxxxxxxx, 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, or at such other time, date or place agreed to in writing by Parent and the Company. The date on which the Closing occurs is referred to in this Agreement as the "Closing Date".
Β Β Β Β Β Β Β Β SectionΒ 2.03.Β Β Β Β Effective Time.Β Β Β Β Upon the terms and subject to the conditions set forth in this Agreement, as soon as practicable on or after the Closing Date, a certificate of merger or other appropriate documents (in any such case, the "Certificate of Merger") shall be duly prepared, executed, acknowledged and delivered by Merger Sub and the Company in accordance with the relevant provisions of the DGCL and filed with the Secretary of State of the State of Delaware. The Merger shall become effective upon the filing of the Certificate of Merger with the Secretary of State of the State of Delaware or at such subsequent time or date (not later than 90Β days after the date of filing) as Parent and the Company shall agree and specify in the Certificate of Merger. The time at which the Merger becomes effective is referred to in this Agreement as the "Effective Time".
7
Β Β Β Β Β Β Β Β SectionΒ 2.04.Β Β Β Β Effects of the Merger.Β Β Β Β The Merger shall have the effects set forth in SectionΒ 259 of the DGCL.
Β Β Β Β Β Β Β Β SectionΒ 2.05.Β Β Β Β Certificate of Incorporation and By-Laws.Β Β Β Β (a)Β At the Effective Time, the Certificate of Incorporation of the Surviving Corporation shall be amended in its entirety to read as the Certificate of Incorporation of Merger Sub, as in effect immediately prior to the Effective Time, until thereafter changed or amended as provided therein or by applicable law; provided, however, that the Certificate of Incorporation of the Surviving Corporation shall provide that the Surviving Corporation shall be named "Information Resources,Β Inc." and shall contain indemnification provisions consistent with the obligations set forth in SectionΒ 5.12(a).
Β Β Β Β Β Β Β Β (b)Β Β Β The By-laws of Merger Sub, as in effect immediately prior to the Effective Time, shall be the By-laws of the Surviving Corporation until thereafter changed or amended as provided therein or by applicable law; provided that the By-Laws of the Surviving Corporation shall contain indemnification provisions consistent with the obligations set forth in SectionΒ 5.12(a).
Β Β Β Β Β Β Β Β SectionΒ 2.06.Β Β Β Β Directors.Β Β Β Β The directors of Merger Sub immediately prior to the Effective Time shall be the directors of the Surviving Corporation until the earlier of their resignation or removal or until their respective successors are duly elected and qualified, as the case may be.
Β Β Β Β Β Β Β Β SectionΒ 2.07.Β Β Β Β Officers.Β Β Β Β The officers of the Company immediately prior to the Effective Time shall be the officers of the Surviving Corporation until the earlier of their resignation or removal or until their respective successors are appointed and qualified, as the case may be.
Β Β Β Β Β Β Β Β SectionΒ 2.08.Β Β Β Β Effect on Capital Stock.Β Β Β Β At the Effective Time, by virtue of the Merger and without any action on the part of the holder of any shares of capital stock of the Company, Parent or Merger Sub:
Β Β Β Β Β Β Β Β (a)Β Β Β Β Capital Stock of Sub.Β Β Β Β Each issued and outstanding share of common stock of Merger Sub, par value $0.01 per share, that is issued and outstanding immediately prior to the Effective Time shall be converted into and become one fully paid and nonassessable share of common stock of the Surviving Corporation.
Β Β Β Β Β Β Β Β (b)Β Β Β Β Cancellation of Treasury Stock and Stock Owned by Parent.Β Β Β Β Each share of Company Common Stock that is owned by the Company (as treasury stock), Parent, Merger Sub or any of their respective Subsidiaries immediately prior to the Effective Time shall automatically be cancelled and retired and shall cease to exist and no consideration shall be delivered in exchange therefor.
Β Β Β Β Β Β Β Β (c)Β Β Β Β Conversion of Company Common Stock.Β Β Β Β Each share of Company Common Stock that is issued and outstanding immediately prior to the Effective Time (other than shares to be cancelled in accordance with SectionΒ 2.08(b)) and the Appraisal Shares (as defined in SectionΒ 2.08(d)) shall be converted into the right to receive from the Surviving Corporation (i)Β in cash, without interest, $3.30 per share (the "Cash Consideration") and (ii)Β one contingent value right (a "CVR") which shall represent the contingent right to receive an amount
8
of cash equal to the CVR Payment Amount (as defined in the CVR Agreement). The Cash Consideration and the CVR to be received in respect of each such share of Company Common Stock pursuant to this SectionΒ 2.08(c) are together defined herein as the "Merger Consideration". At the Effective Time all such shares of Company Common Stock shall no longer be outstanding and shall automatically be cancelled and shall cease to exist, and each holder of a certificate that immediately prior to the Effective Time represented any such shares (a "Certificate") shall cease to have any rights with respect thereto, except the right to receive the Merger Consideration (without any interest being payable thereon).
Β Β Β Β Β Β Β Β (d)Β Β Β Β Appraisal Rights.Β Β Β Β Notwithstanding anything in this Agreement to the contrary, shares (the "Appraisal Shares") of Company Common Stock that are issued and outstanding immediately prior to the Effective Time and are held by any holder who is entitled to demand and properly demands appraisal of such shares pursuant to, and who complies in all respects with, the provisions of SectionΒ 262 of the DGCL ("SectionΒ 262"), if SectionΒ 262 provides for appraisal rights for such shares, shall not be converted into the right to receive the Merger Consideration as provided in SectionΒ 2.08(c), but instead such holder shall be entitled to payment of the fair value of such shares in accordance with the provisions of SectionΒ 262. At the Effective Time, all Appraisal Shares shall no longer be outstanding and shall automatically be canceled and shall cease to exist, and each holder of Appraisal Shares shall cease to have any rights with respect thereto, except the right to receive the fair value of such shares in accordance with the provisions of SectionΒ 262. Notwithstanding the foregoing, if any such holder shall fail to perfect or otherwise shall waive, withdraw or lose the right to appraisal under SectionΒ 262 or a court of competent jurisdiction shall determine that such holder is not entitled to the relief provided by SectionΒ 262, then the right of such holder to be paid the fair value of such holder's Appraisal Shares under SectionΒ 262 shall cease, and each such Appraisal Share shall be deemed to have been converted into, and shall have become, in each case at the Effective Time, the right to receive the Merger Consideration only (without any interest being payable thereon) as provided in SectionΒ 2.08(c). The Company shall serve prompt notice to Parent of any demands for appraisal of any shares of Company Common Stock, and Parent shall have the opportunity to participate in and direct all negotiations and proceedings with respect to such demands. Prior to the Effective Time, the Company shall not, without the prior written consent of Parent, make any payment with respect to, or settle or offer to settle, any such demands, or agree to do any of the foregoing.
Β Β Β Β Β Β Β Β SectionΒ 2.09.Β Β Β Β Exchange of Certificates.Β Β Β Β (a)Β Paying Agent. Prior to the Effective Time, Parent shall designate, or shall cause to be designated, a bank or trust company reasonably acceptable to the Company to act as agent for the payment of the Merger Consideration upon surrender of Certificates (the "Paying Agent"), and, from time to time after the Effective Time, Parent shall provide, or cause the Surviving Corporation to provide, to the Paying Agent funds in amounts and at the times necessary for the payment of the Cash Consideration pursuant to SectionΒ 2.08(c) promptly after the surrender of Certificates, it being understood that any and all interest or income earned on funds made available to the Paying Agent pursuant to this Agreement shall be turned over to, and shall be deemed to be the property of, Parent.
Β Β Β Β Β Β Β Β (b)Β Β Β Exchange Procedure. As soon as reasonably practicable after the Effective Time, the Paying Agent shall mail to each holder of record of a Certificate (i)Β a form of letter of
9
transmittal (which shall specify that delivery shall be effected, and risk of loss and title to the Certificates held by such person shall pass, only upon proper delivery of the Certificates to the Paying Agent and shall be in customary form and have such other provisions as Parent may reasonably specify) and (ii)Β instructions for use in effecting the surrender of the Certificates in exchange for the Merger Consideration. Upon surrender of a Certificate for cancellation to the Paying Agent or to such other agent or agents as may be appointed by Parent, together with such letter of transmittal, duly completed and validly executed, and such other documents as may reasonably be required by the Paying Agent, the holder of such Certificate shall be entitled to receive in exchange therefor the amount of the Cash Consideration and the number of CVRs into which the shares formerly represented by such Certificate shall have been converted pursuant to SectionΒ 2.08(c), and the Certificate so surrendered shall forthwith be cancelled. In the event of a transfer of ownership of Company Common Stock that is not registered in the stock transfer books of the Company, the proper Merger Consideration may be paid in exchange therefor to a person other than the person in whose name the Certificate so surrendered is registered if such Certificate shall be properly endorsed or otherwise be in proper form for transfer and the person requesting such payment shall pay any transfer or other taxes required by reason of the payment to a person other than the registered holder of such Certificate or establish to the satisfaction of Parent that such tax has been paid or is not applicable. No interest shall be paid or shall accrue on the Cash Consideration or the CVR(s) payable upon surrender of any Certificate.
Β Β Β Β Β Β Β Β (c)Β Β Β No Further Ownership Rights in Company Common Stock. All Merger Consideration paid or issued upon the surrender of a Certificate in accordance with the terms of this ArticleΒ II shall be deemed to have been paid in full satisfaction of all rights pertaining to the shares of Company Common Stock formerly represented by such Certificate. Upon and after the Effective Time, the stock transfer books of the Company shall be closed, and there shall be no further registration of transfers on the stock transfer books of the Surviving Corporation of the shares of Company Common Stock that were outstanding immediately prior to the Effective Time. If, after the Effective Time, Certificates are presented to the Surviving Corporation or the Paying Agent for transfer or any other reason, they shall be cancelled and exchanged as provided in this ArticleΒ II.
Β Β Β Β Β Β Β Β (d)Β Β Β No Liability. None of Parent, Merger Sub, the Company or the Paying Agent shall be liable to any person in respect of any cash delivered to a public official pursuant to any applicable abandoned property, escheat or similar law. All funds held by the Paying Agent for payment to the holders of unsurrendered Certificates and unclaimed at the end of one year after the Effective Time shall be returned to the Surviving Corporation, after which time any holder of unsurrendered Certificates shall look as a general creditor only to Parent for payment and issuance of the Merger Consideration (without any interest being payable thereon) to which such holder may be due, subject to applicable law. Any amounts remaining unclaimed by holders of shares of Company Common Stock seven years after the Effective Time (or such earlier date immediately before that time when the amounts would otherwise escheat to or become property of any governmental authority) shall become, to the extent permitted by applicable law, the property of Parent free and clear of any claims or interest of any person previously (or subsequently claiming to be) entitled thereto. Any portion of the Merger Consideration made available to the Paying Agent pursuant to SectionΒ 2.09(a) to pay for Appraisal Shares shall be returned to Parent, upon demand.
10
Β Β Β Β Β Β Β Β (e)Β Β Β Lost Certificates. If any Certificate shall have been lost, stolen or destroyed, upon the making of an affidavit of that fact by the holder claiming such Certificate to be lost, stolen or destroyed and, if required by the Surviving Corporation, the posting by such person of a bond in such reasonable amount as the Surviving Corporation may direct as indemnity against any claim that may be made against it with respect to such Certificate, the Paying Agent shall pay and issue the Merger Consideration in respect of each share of Company Common Stock represented by such lost, stolen or destroyed Certificate.
Β Β Β Β Β Β Β Β (f)Β Β Β Β Withholding Rights. Parent, the Surviving Corporation or the Paying Agent shall be entitled to deduct and withhold from the consideration otherwise payable pursuant to this Agreement or the CVR Agreement to any holder of shares of Company Common Stock (or of CVRs, a Company Option (as defined in SectionΒ 2.10) or Restricted Shares (as defined in SectionΒ 2.11)) such amounts as Parent, the Surviving Corporation or the Paying Agent is required to deduct and withhold with respect to the making of any such payment under the Internal Revenue Code of 1986, as amended, and the rules and regulations promulgated thereunder (the "Code"), or any provision of state, local or foreign tax law. To the extent that amounts are so withheld and paid over to the appropriate taxing authority by Parent, the Surviving Corporation or the Paying Agent, such withheld amounts shall be treated for all purposes of this Agreement as having been paid to the holder of the shares of Company Common Stock (or of CVRs, a Company Option or Restricted Shares) in respect of which such deduction and withholding was made by Parent, the Surviving Corporation or the Paying Agent.
Β Β Β Β Β Β Β Β SectionΒ 2.10.Β Β Β Β Options.Β Β Β Β At the Effective Time, all outstanding and unexercised options to purchase shares of Company Common Stock granted under any of the Company Option Plans (each, a "Company Option"), whether or not exercisable or vested, shall be cancelled, and each holder of a Company Option shall be entitled to receive, in full satisfaction of such Company Option, (i)Β cash in an amount equal to the product of (A)Β the excess, if any, of the Cash Consideration over the exercise price per share thereof and (B)Β the number of shares of Company Common Stock subject to such Company Option and (ii)Β if cash is paid pursuant to clauseΒ (i) hereof, one CVR per share of Company Common Stock subject to such Company Option.
Β Β Β Β Β Β Β Β SectionΒ 2.11.Β Β Β Β Restricted Stock.Β Β Β Β At the Effective Time, any restricted shares of Company Common Stock held by current or former employees and awarded pursuant to the Company's Nonqualified Defined Contribution Plan or any individual employment agreement (collectively, the "Restricted Shares") which are outstanding immediately prior to the Effective Time shall be converted into the right to receive the Merger Consideration in accordance with SectionΒ 2.08(c) hereof.
ARTICLE III
REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB
Β Β Β Β Β Β Β Β Parent and Merger Sub jointly and severally represent and warrant to the Company that:
11
Β Β Β Β Β Β Β Β SectionΒ 3.01.Β Β Β Β Organization and Qualification.Β Β Β Β Each of Parent and Merger Sub is a corporation duly organized and validly existing under the laws of the state of its incorporation and has the requisite corporate power and authority to own, lease and operate its assets and properties and to carry on its business as it is now being conducted or as contemplated herein. Merger Sub is a wholly-owned Subsidiary of Parent.
Β Β Β Β Β Β Β Β SectionΒ 3.02.Β Β Β Β Authority; Non-Contravention; Approvals.Β Β Β Β (a)Β Each of Parent and Merger Sub has full corporate power and authority to enter into this Agreement and the CVR Agreement and to consummate the transactions contemplated hereby and thereby. This Agreement and the CVR Agreement have been unanimously approved by the Board of Directors of each of Parent and Merger Sub, and by Parent as sole stockholder in Merger Sub, and no other corporate proceedings on the part of either Parent or Merger Sub are necessary to authorize the execution and delivery of this Agreement or the CVR Agreement or the consummation by each of Parent and Merger Sub of the transactions contemplated hereby and thereby. Each of this Agreement and the CVR Agreement has been duly executed and delivered by each of Parent and Merger Sub, and, assuming the due authorization, execution and delivery hereof and thereof by the Company, constitutes a valid and legally binding agreement of each of Parent and Merger Sub, enforceable against each of Parent and Merger Sub in accordance with its terms, except that such enforcement may be subject to (i)Β bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting or relating to enforcement of creditors' rights generally and (ii)Β general equitable principles.
Β Β Β Β Β Β Β Β (b)Β Β Β The execution, delivery and performance of this Agreement and the CVR Agreement by each of Parent and Merger Sub and the consummation of the transactions contemplated hereby and thereby do not and will not violate, conflict with or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration under, or require any offer to purchase or any prepayment of any debt or result in the creation of any lien, security interest or encumbrance upon any of the properties or assets of Parent or any of its Subsidiaries under any of the terms, conditions or provisions of (i)Β the respective certificates of incorporation or by-laws or similar organizational documents of Parent, Merger Sub or any Subsidiary of Parent, (ii)Β any statute, law, ordinance, rule, regulation, judgment, decree, order, injunction, writ, permit or license of any court or governmental authority applicable to Parent, Merger Sub or any Subsidiary of Parent or any of their respective properties or assets, subject in the case of consummation, to obtaining the Parent Required Statutory Approvals (as defined in SectionΒ 3.02(c)) prior to the Acceptance Date, or (iii)Β any loan or credit agreement, bond, debenture, note, mortgage, indenture, guarantee, lease or other agreement, contract, commitment, obligation, undertaking, permit, concession, franchise or license or other binding instrument, whether oral or written (each, including all amendments thereto, a "Contract") to which Parent, Merger Sub or any Subsidiary of Parent is a party or by which Parent, Merger Sub or any Subsidiary of Parent or any of their respective properties or assets may be bound or affected, other than, in the case of (ii)Β and (iii)Β above, such violations, conflicts, breaches, defaults, terminations, accelerations, offers, prepayments or creations of liens, security interests or encumbrances that are not reasonably likely to prevent or materially impede or delay the consummation of the Offer, the Merger or the other transactions contemplated hereby and thereby. For purposes of this Agreement the term "Subsidiary" means, with respect to any
12
Person (as defined in SectionΒ 3.06), any entity of which securities or other ownership interests having ordinary voting power to elect a majority of the board of directors or other persons performing similar functions are at any time directly or indirectly owned by that Person.
Β Β Β Β Β Β Β Β (c)Β Β Β Except for (i)Β any filings by Parent and Merger Sub that may be required by the Xxxx-Xxxxx-Xxxxxx Antitrust Improvements Act of 1976, as amended (the "HSR Act"), (ii)Β any filings by Parent and Merger Sub required by, and approvals under, foreign antitrust and competition laws ("Foreign Antitrust Laws"), (iii)Β the applicable requirements of the Exchange Act and the Securities Act of 1933, as amended and together with the rules and regulations promulgated thereunder (collectively, the "Securities Act"), if any, (iv)Β the filing and recordation of appropriate merger documents as required by the DGCL, (v)Β any filings with or approvals from authorities required solely by virtue of the jurisdictions in which the Company or its Subsidiaries conduct any business or own any assets and (vi)Β any required filings with or approvals from applicable domestic or foreign environmental authorities (the filings and approvals referred to in clauses (i)Β through (vi)Β collectively referred to as the "Parent Required Statutory Approvals"), no declaration, filing or registration with, or notice to, or authorization, consent or approval of, any governmental or regulatory body or authority is necessary for the execution and delivery of this Agreement or the CVR Agreement by Parent or Merger Sub or the consummation by Parent and Merger Sub of the transactions contemplated hereby and thereby, other than such declarations, filings, registrations, notices, authorizations, consents or approvals which, if not made or obtained, as the case may be, whether individually and in the aggregate, would not prevent or materially impair or delay the ability of Parent or Merger Sub to perform its obligations under this Agreement or the CVR Agreement (including, but not limited to the consummation of the Offer, the Merger and the other transactions contemplated hereby and thereby) or subject Parent or any of its Subsidiaries or any of its or their officers, directors or employees to any criminal liability.
Β Β Β Β Β Β Β Β SectionΒ 3.03.Β Β Β Β Interim Operations of Merger Sub.Β Β Β Β Parent and Merger Sub were formed solely for the purpose of engaging in the transactions contemplated hereby and by the CVR Agreement, and neither such entity has engaged in any business or incurred any liabilities other than in connection with the transactions contemplated by this Agreement and the CVR Agreement.
Β Β Β Β Β Β Β Β SectionΒ 3.04.Β Β Β Β Capital Resources.Β Β Β Β On or prior to the expiration of the Offer Parent and Merger Sub will have sufficient cash resources to pay for all shares of Company Common Stock validly tendered into and not withdrawn from the Offer and all associated costs and expenses. On or prior to the consummation of the Merger, Parent and Merger Sub will have sufficient cash resources to pay the Merger Consideration for all remaining shares of Company Common Stock and all associated costs and expenses. Parent has received and provided accurate and complete copies to the Company of commitment letters (collectively, the "Commitment Letters") from each of entities managed by Xxxxxxxxxx Capital Partners, LLC (collectively, "Xxxxxxxxxx") any Symphony Technology II-A, L.P. ("Symphony") dated as of the date of this Agreement pursuant to which Xxxxxxxxxx and Symphony have, severally and not jointly, committed, pursuant to the terms and subject to the conditions stated in the Commitment Letter of such Person, to provide the respective equity and debt capital amounts described in the Commitment Letter of such Person to Parent to be used by Parent to pay the cash portion of the Merger Consideration and the Offer Price. The Commitment Letters and other assets and rights
13
of Parent are sufficient to provide the funds that are necessary to consummate the Offer, the Merger and the transactions contemplated hereby, and have been duly accepted by Parent and are in full force and effect. All fees required to be paid by Parent or Merger Sub on or prior to the date hereof in respect of the Commitment Letters have been paid by Parent or Merger Sub.
Β Β Β Β Β Β Β Β SectionΒ 3.05.Β Β Β Β Offer Documents; Proxy Statement.Β Β Β Β Neither the Offer Documents nor any information supplied by Parent or Merger Sub for inclusion in the ScheduleΒ 14D-9 will, at the time that the Offer Documents, the ScheduleΒ 14D-9, or any amendments or supplements thereto, are filed with the SEC or are first published, sent or given to stockholders of the Company, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they were made, not misleading. The information supplied by Parent for inclusion in any proxy or information statement to be sent to stockholders of the Company in connection with a meeting of the Company's stockholders to consider and vote on the Merger (the "Company Meeting") (such proxy or information statement, as amended or supplemented, the "Proxy Statement"), on the date that the Proxy Statement (or any amendment or supplement thereto) is first mailed to stockholders of the Company and at the time of the Company Meeting, will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading. Notwithstanding the foregoing, Parent and Merger Sub make no representation or warranty with respect to any information supplied by or on behalf of the Company which is contained in any of the Offer Documents, the Proxy Statement or any amendment or supplement thereto. The Offer Documents shall comply as to form in all material respects with the requirements of the Exchange Act and the Securities Act, if applicable.
Β Β Β Β Β Β Β Β SectionΒ 3.06.Β Β Β Β Interest in the Company.Β Β Β Β Immediately prior to the execution and delivery of this Agreement, neither Parent nor any of its Subsidiaries beneficially owned any shares of Company Common Stock. As of the date hereof, neither Parent nor any of its Affiliates is an "Interested Stockholder" as such term is defined in SectionΒ 203 of the DGCL, or an "Acquiring Person" as such term is defined in the Company Rights Agreement. For purposes of this Agreement, the term "Affiliate" means, with respect to any Person, any other Person directly or indirectly, controlling, controlled by, or under common control with, the first such Person. As used in the preceding sentence, (A)Β "control" means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of such Person, whether through the ownership of voting securities, by contract or otherwise and (B)Β "Person" means any natural person, corporation, partnership, limited liability company, joint venture, trust, association, unincorporated entity of any kind or governmental authority.
Β Β Β Β Β Β Β Β SectionΒ 3.07.Β Β Β Β Brokers and Finders.Β Β Β Β Neither Parent nor Merger Sub has entered into any contract, arrangement or understanding with any person or firm which may result in the obligation of Parent or Merger Sub to pay any investment banking fees, finder's fees, brokerage or agent commissions or other like payments in connection with the transactions contemplated hereby, for which, or with respect to which, the Company is or might be liable.
14
Β Β Β Β Β Β Β Β SectionΒ 3.08.Β Β Β Β Settlement Negotiations.Β Β Β Β None of Parent nor any of its Affiliates (including Merger Sub) have had any settlement negotiations or other discussions with the parties to the Litigation (as defined in the CVR Agreement) other than the Company.
ARTICLE IV
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Β Β Β Β Β Β Β Β The Company represents and warrants to Parent and Merger Sub that, except as set forth in the disclosure schedule dated as of the date hereof and attached to this Agreement (which disclosure schedule shall make a specific reference to the particular Section of this Agreement to which exception is being taken or to which the relevant disclosure relates, as applicable) (the "Company Disclosure Schedule"):
Β Β Β Β Β Β Β Β SectionΒ 4.01.Β Β Β Β Organization and Qualification.Β Β Β Β The Company is a corporation duly organized and validly existing under the laws of the State of Delaware and has the requisite corporate power and authority to own, lease and operate its assets and properties and to carry on its business as it is now being conducted or as contemplated hereby or by the CVR Agreement. The Company is qualified to transact business and, where applicable, is in good standing in each jurisdiction in which the properties owned, leased or operated by it or the nature of the business conducted by it makes such qualification necessary, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. True, accurate and complete copies of the Company's Amended and Restated Certificate of Incorporation and Bylaws, in each case as in effect on the date hereof, including all amendments thereto, have heretofore been filed with the SEC or delivered to Parent.
Β Β Β Β Β Β Β Β For purposes of this Agreement, the term "Company Material Adverse Effect" shall mean any effect or change that is materially adverse to (i)Β the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole, or (ii)Β the ability of the Company to perform its obligations hereunder or under the CVR Agreement or to consummate the transactions contemplated hereby or thereby, except, in each case, for any such effect or change resulting from or arising out of (x)Β any loss of customers or revenue resulting from the fact that Parent will become the owner of the Company upon consummation of the transactions contemplated by this Agreement, (y)Β the condition of the United States economy or financial markets generally or (z)Β a condition generally affecting participants in the industry in which the Company competes, unless in the case of clauses (y)Β and (z)Β such condition has a disproportionate effect on the business, financial condition or results of operations of the Company and its Subsidiaries, taken as a whole, in which case such condition shall be taken into account in determining whether or not there has been, or there would reasonably be expected to be a Company Material Adverse Effect.
Β Β Β Β Β Β Β Β SectionΒ 4.02.Β Β Β Β Capitalization.Β Β Β Β (a)Β The authorized capital stock of the Company consists of 60,000,000 shares of Company Common Stock and 1,000,000 shares of preferred stock, par value $0.01 (the "Company Preferred Shares"). As of MayΒ 31, 2003, (i)Β 29,861,295 shares of Company Common Stock, including in each case the associated Company Rights (as defined in SectionΒ 4.02(b)), no stock appreciation rights (the "SAR's") and no Company
15
Preferred Shares, were issued and outstanding, all of which shares of Company Common Stock were validly issued and are fully paid, nonassessable and free of preemptive rights, (ii)Β no shares of Company Common Stock were held in the treasury of the Company, (iii)Β 9,767,185 shares of Company Common Stock were reserved for issuance upon exercise of Company Options issued and outstanding, (iv)Β 1,082,750 Restricted Shares were outstanding and (v)Β 257,043 shares of Company Common Stock that were reserved for issuance under the Directors' Plan (as defined below). Since MayΒ 31, 2003 except after the date hereof as permitted by this Agreement, (i)Β no shares of Company Common Stock or Company Preferred Shares have been issued, except for shares of Company Common Stock issued pursuant to the exercise of Company Options outstanding on MayΒ 31, 2003 and except for shares of Company Common Stock required to be issued in connection with the Company's Amended and Restated 401(k) Retirement Savings Plan (the "401(k) Plan"), the Company's 2000 Employee Stock Purchase Plan (the "ESPP"), the Company's Nonqualified Defined Contribution Plan (the "DCP") and the Company's 1996 Directors' Plan (the "Directors' Plan") and (ii)Β no options, warrants, securities convertible into, or exchangeable for, or commitments with respect to the issuance of, shares of capital stock of the Company have been issued, granted or made, except the Company Rights in accordance with the terms of the Company Rights Agreement that are issued in connection with the Company Common Stock pursuant to the exercise of Company Options outstanding on MayΒ 31, 2003.
Β Β Β Β Β Β Β Β (b)Β Β Β As of the date hereof, except for (i)Β the Preferred Share Purchase Rights (the "Company Rights") issued pursuant to the Rights Agreement, as amended and restated (the "Company Rights Agreement"), dated as of MarchΒ 2, 1989, by and between the Company and Xxxxxx Trust and Savings Bank (the "Company Rights Agent"), (ii)Β the 8,897,422 Company Options that were issued and outstanding on MayΒ 31, 2003, (iii)Β rights that were outstanding on MayΒ 31, 2003 under the 401(k) Plan, the ESPP, and the Directors' Plan and (iv)Β the 1,082,750 Restricted Shares, there were no outstanding subscriptions, options, calls, contracts, commitments, understandings, restrictions, arrangements, rights or warrants, including any right of conversion or exchange under any outstanding security, instrument or other agreement and also including any rights plan or other anti-takeover agreement, obligating the Company or any Subsidiary of the Company to issue, deliver or sell, or cause to be issued, delivered or sold, additional shares of Company Common Stock or Company Preferred Shares (or any securities, directly or indirectly, convertible into, or exchangeable or exercisable for, any other shares of the capital stock or other equity interests of the Company) or obligating the Company or any Subsidiary of the Company to grant, extend, perform or enter into any such agreement or commitment. As of the date hereof, there are no obligations, contingent or otherwise, of the Company or any of its Subsidiaries to (i)Β repurchase, redeem or otherwise acquire any shares of Company Common Stock, any Company Preferred Shares or the capital stock or other equity interests of the Company or any of its Subsidiaries (or any securities, directly or indirectly, convertible into, or exchangeable or exercisable for, any other shares of the capital stock or other equity interests of the Company), except in connection with the issuance of shares of Company Common Stock and the associated Company Rights upon the exercise of Company Options issued and outstanding on MayΒ 31, 2003 or (ii)Β other than as set forth in SectionΒ 4.02(b) of the Company Disclosure Schedule, provide material funds to, or make any material investment in (in the form of a loan, capital contribution or otherwise), or provide any guarantee with respect to or security for the obligations of, any Subsidiary of the Company or any other Person. There are no outstanding stock appreciation rights or similar derivative securities or rights of the Company or any of its Subsidiaries. There are no bonds, debentures, notes or other indebtedness of the
16
Company having the right to vote (or convertible into, or exchangeable for, securities having the right to vote) on any matters on which stockholders of the Company may vote. Except as otherwise expressly contemplated by this Agreement, there are no voting trusts, irrevocable proxies or other agreements or understandings to which the Company or any Subsidiary of the Company is a party or is bound with respect to the voting of any shares of Company Common Stock. The Board of Directors of the Company has taken all action (subject only to execution of such amendment by the Company Rights Agent which the Company has obtained or will obtain as soon as practicable after the date hereof) to amend the Company Rights Agreement to provide that, for so long as this Agreement is in full force and effect, (i)Β none of the Parent and its Affiliates (including, but not limited to, Merger Sub) shall become an "Acquiring Person" and no "Stock Acquisition Date" shall occur as a result of the announcement, execution, delivery or performance of this Agreement or the CVR Agreement or the consummation of the Offer, the Top-Up Closing or the Merger or any other action or transaction contemplated hereby or thereby or in connection herewith or therewith, (ii)Β no "Distribution Date" shall occur as a result of the announcement, execution, delivery or performance of this Agreement or the CVR Agreement or the consummation of the Offer, the Top-Up Closing or the Merger or any other action or transaction contemplated hereby or thereby or in connection herewith or therewith.
Β Β Β Β Β Β Β Β (c)Β Β Β The Company has filed with the SEC or previously made available to Parent complete and correct copies of the Amended and Restated 1992 Stock Option Plan, the Amended and Restated 1992 Executive Stock Option Plan, the 1984 Non-Qualified Stock Option Plan and the Amended and Restated 1994 Employee Nonqualified Stock Option Plan (the "Company Option Plans") and the Directors' Plan, including all amendments thereto. SectionΒ 4.02(c) of the Company Disclosure Schedule contains a correct and complete list as of MayΒ 31, 2003 of each outstanding Company Option and Restricted Share, including the holder, date of grant, expiration date, exercise price, vesting schedule and aggregate number of Company Common Shares subject thereto (vested and unvested) and setting forth the weighted average exercise price for all outstanding Company Options.
Β Β Β Β Β Β Β Β (d)Β Β Β Since DecemberΒ 31, 2002, there has not been (i)Β any declaration, setting aside or payment of any dividend or other distribution with respect to any shares of capital stock of the Company, (ii)Β any repurchase, redemption or other acquisition by the Company of any outstanding shares of capital stock or other securities of, or other ownership interests in, the Company or (iii)Β any amendment of any material term of any outstanding security of the Company or any of its Subsidiaries.
Β Β Β Β Β Β Β Β SectionΒ 4.03.Β Β Β Β Subsidiaries.Β Β Β Β Each Subsidiary of the Company is duly organized, validly existing and, where applicable, in good standing under the laws of its jurisdiction of organization and has the requisite power and authority to own, lease and operate its assets and properties and to carry on its business as it is now being conducted and each Subsidiary of the Company is qualified to transact business, and is in good standing, in each jurisdiction in which the properties owned, leased or operated by it or the nature of the business conducted by it makes such qualification necessary; except in all cases as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. (i)Β All of the outstanding shares of capital stock of each Subsidiary of the Company are validly issued, fully paid, nonassessable and free of preemptive rights, liens and any other limitation or restriction, (ii)Β all such shares are owned directly or indirectly by the Company, and (iii)Β there are no outstanding
17
(A)Β securities of the Company or any of its Subsidiaries convertible into or exchangeable for shares of capital stock of or other voting securities or ownership interests in any such Subsidiary or (B)Β options or other rights to acquire from the Company or any of its Subsidiaries, or other obligation of the Company or any such Subsidiary to issue, any capital stock of or other voting securities or ownership interests in, or any securities convertible into or exchangeable for any capital stock of or other voting securities or ownership interests in, any such Subsidiary (the outstanding shares of the capital stock of each Subsidiary of the Company, together with the items in clauses (A)Β and (B)Β being referred to collectively as the "Company Subsidiary Securities"). There are no subscriptions, options, warrants, voting trusts, proxies or other commitments, understandings, restrictions or arrangements relating to the issuance, sale, voting or transfer of any Company Subsidiary Securities, and there are no outstanding obligations of the Company or any of its Subsidiaries to repurchase, redeem or otherwise acquire any of the Company Subsidiary Securities. The Company has no material investment in any entity, other than its Subsidiaries, and no other entity in which the Company has an investment is material to the Company or any of its business segments. Since DecemberΒ 31, 2002, there has not been any making of any loan, advance or capital contributions by the Company or any of its Subsidiaries to or any other investment in any Person, other than loans, advances or capital contributions to or investments in its wholly owned Subsidiaries made in the ordinary course of business consistent with past practices.
Β Β Β Β Β Β Β Β SectionΒ 4.04.Β Β Β Β Authority; Non-Contravention; Approvals.Β Β Β Β (a)Β The Company has full corporate power and authority to enter into this Agreement and the CVR Agreement and, subject to the approval of the stockholders of the Company if required by the DGCL (the "Company Stockholder Approval"), to consummate the transactions contemplated hereby and thereby. This Agreement and the CVR Agreement have been approved by the Board of Directors of the Company, and no other corporate proceedings on the part of the Company are necessary to authorize the execution and delivery of this Agreement or the CVR Agreement or, except for the Company Stockholder Approval (if required by the DGCL), the consummation by the Company of the transactions contemplated hereby and thereby. Each of this Agreement and the CVR Agreement has been duly executed and delivered by the Company, and, assuming the due authorization, execution and delivery hereof and thereof by Parent and Merger Sub, constitutes a valid and legally binding agreement of the Company, enforceable against the Company in accordance with its terms, except that such enforcement may be subject to (i)Β bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting or relating to enforcement of creditors' rights generally and (ii)Β general equitable principles.
Β Β Β Β Β Β Β Β (b)Β Β Β The execution, delivery and performance of this Agreement and the CVR Agreement by the Company and the consummation of the transactions contemplated hereby and thereby do not and will not violate, conflict with or result in a breach of any provision of, or constitute a default (or an event which, with notice or lapse of time or both, would constitute a default) under, or result in the termination of, or accelerate the performance required by, or result in a right of termination or acceleration under, or require any offer to purchase or any prepayment of any debt or result in the creation of any lien, security interest or encumbrance upon any of the properties or assets of the Company or any of its Subsidiaries, or the loss of any asset, right or benefit of the Company or any of its Subsidiaries under any of the terms, conditions or provisions of (i)Β the respective certificates of incorporation or bylaws or similar organizational documents of the Company or any of its Subsidiaries, (ii)Β any statute, law,
18
ordinance, rule, regulation, judgment, decree, order, injunction, writ, permit or license of any court or governmental authority applicable to the Company or any of its Subsidiaries or any of their respective properties or assets, subject in the case of consummation, to obtaining (prior to the Acceptance Date) the Company Required Statutory Approvals and prior to the Effective Time, the Company Stockholder Approval, or (iii)Β any Contract to which the Company or any of its Subsidiaries is a party or by which the Company or any of its Subsidiaries or any of their respective properties or assets may be bound or affected, other than, in the case of (ii)Β and (iii)Β above, such violations, conflicts, breaches, defaults, terminations, accelerations or creations of liens, security interests or encumbrances that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or prevent or materially impede or delay the consummation of the Offer, the Merger or the other transactions contemplated hereby and thereby.
Β Β Β Β Β Β Β Β (c)Β Β Β Except for (i)Β any filings by the Company that may be required by the HSR Act, (ii)Β any filings by the Company required by, and approvals under, Foreign Antitrust Laws, (iii)Β the applicable requirements of the Exchange Act and the Securities Act, if any, (iv)Β the filing and recordation of appropriate merger documents as required by the DGCL, (v)Β any filings with or approvals from authorities required solely by virtue of the jurisdictions in which Parent or its Subsidiaries conduct any business or own any assets and (vi)Β any required filings with or approvals from applicable domestic or foreign environmental authorities (the filings and approvals referred to in clauses (i)Β through (vi)Β are collectively referred to herein as the "Company Required Statutory Approvals"), no declaration, filing or registration with, or notice to, or authorization, consent or approval of, any governmental or regulatory body or authority is necessary for the execution and delivery of this Agreement or the CVR Agreement by the Company or the consummation by the Company of the transactions contemplated hereby or thereby, other than such declarations, filings, registrations, notices, authorizations, consents or approvals which, if not made or obtained, as the case may be, (x)Β individually and in the aggregate, would not prevent or materially impede or delay the ability of the Company to perform its obligations under this Agreement or the CVR Agreement or prevent or materially impede or delay the consummation of the Offer, the Merger and the other transactions contemplated hereby or thereby, (y)Β would not reasonably be expected to have a Company Material Adverse Effect or (z)Β subject the Company or any of its Subsidiaries or any its or their officers, directors or employees to any criminal liability.
Β Β Β Β Β Β Β Β (d)Β Β Β The Board of Directors of the Company, at a meeting duly called and held, duly and unanimously adopted resolutions that are still in full force and effect as of the date hereof and, subject to SectionΒ 5.03 of this Agreement, will remain in full force and effect, (i)Β approving and declaring advisable the Offer, the Merger, this Agreement, the CVR Agreement and the transactions contemplated hereby and thereby, (ii)Β declaring that it is in the best interests of the Company's stockholders that the Company enter into this Agreement and the CVR Agreement and consummate the Offer, the Merger and the other transactions contemplated hereby and thereby, on the terms and subject to the conditions set forth in this Agreement, (iii)Β recommending that the Company's stockholders accept the Offer, tender their shares pursuant to the Offer and approve and adopt this Agreement (if required by applicable law), (iv)Β approving the acquisition of the shares of the Company Common Stock by Parent or Merger Sub pursuant to the Offer, the Top-Up Option and the Merger and the other transactions contemplated by this
19
Agreement and by the CVR Agreement and (v)Β exempting this Agreement and the transactions contemplated hereby from the restrictions of SectionΒ 203 of the DGCL.
Β Β Β Β Β Β Β Β SectionΒ 4.05.Β Β Β Β Reports and Financial Statements.Β Β Β Β Since JanuaryΒ 1, 2000, the Company has filed with the SEC all material forms, statements, reports and documents (including all exhibits, posteffective amendments and supplements thereto) (the "Company SEC Reports") required to be filed by it under each of the Securities Act and the Exchange Act, all of which, as amended if applicable, complied in all material respects with all applicable requirements of the appropriate act. As of their respective filing dates except as amended or supplemented prior to the date hereof, in which case as of the filing date of that amendment or supplement, the Company SEC Reports did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading. The audited consolidated financial statements of the Company included in the Company's Annual Report on FormΒ 10-K for the twelve months ended DecemberΒ 31, 2002 and the unaudited financial statements of the Company included in the Company's Quarterly Report on FormΒ 10-Q (the "Company 10-Q") for the quarterly period ended MarchΒ 31, 2003 (collectively, the "Company Financial Statements") have been prepared in accordance with United States generally accepted accounting principles ("GAAP") applied on a consistent basis (except as may be indicated therein or in the notes thereto) and fairly present in all material respects the financial position of the Company and its Subsidiaries as of the dates thereof and the results of their operations and changes in financial position for the periods then ended (subject, in the case of the unaudited financial statements, to normal year-end adjustments). The Company's Annual Report on FormΒ 10-K for the twelve months ended DecemberΒ 31, 2002, the Company 10-Q and the Current Report on FormΒ 8-K filed by the Company on AprilΒ 24, 2003 are collectively referred to as the "Company Recent SEC Reports". Since DecemberΒ 31, 2002, there has not been any change in any method of accounting or accounting principles or practice by the Company or any of its Subsidiaries, except for any such change required by reason of a concurrent change in GAAP or RegulationΒ S-X under the Exchange Act.
Β Β Β Β Β Β Β Β SectionΒ 4.06.Β Β Β Β Absence of Undisclosed Liabilities.Β Β Β Β Except as disclosed in the unaudited financial statements included in the Company 10-Q or in the Company Recent SEC Reports, neither the Company nor any of its Subsidiaries had at MarchΒ 31, 2003, or has incurred since that date, any liabilities or obligations (whether absolute, accrued, contingent or otherwise) of any nature, except (a)Β liabilities, obligations or contingencies which are accrued or reserved against in the balance sheet of the Company 10-Q or reflected in the notes thereto, (b)Β account or trade payables that were incurred in the ordinary course of business and consistent with past practices or (c)Β liabilities, obligations or contingencies which (i)Β would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, or (ii)Β have been discharged or paid in full prior to the date hereof.
Β Β Β Β Β Β Β Β SectionΒ 4.07.Β Β Β Β Absence of Certain Changes or Events.Β Β Β Β Since DecemberΒ 31, 2002, (a)Β the business of the Company and its Subsidiaries has been conducted in the ordinary course consistent with past practices, (b)Β there has not been any event, occurrence or development, and there has not arisen any state of circumstances or facts that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (c)Β any incurrence, assumption or guarantee by the Company or any of its Subsidiaries of
20
any indebtedness for borrowed money, other than in the ordinary course of business and in amounts and on terms that are consistent with past practices; (d)Β any creation or other incurrence by the Company or any of its Subsidiaries of any lien on any asset other than in the ordinary course of business consistent with past practices, (e)Β any damage, destruction or other casualty loss (whether or not covered by insurance) affecting the business or assets of the Company or any of its Subsidiaries that has had or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or (f)Β any transaction or commitment made, or any Contract entered into, by the Company or any of its Subsidiaries relating to its assets or business (including the acquisition or disposition of any assets) or any relinquishment by the Company or any of its Subsidiaries of any contract or other right, in either case, that would reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, other than transactions and commitments in the ordinary course of business consistent with past practices and those contemplated by this Agreement or the CVR Agreement.
Β Β Β Β Β Β Β Β SectionΒ 4.08.Β Β Β Β Litigation.Β Β Β Β Except as disclosed in the Company Recent SEC Reports, as of the date hereof, there are no claims, suits, actions or proceedings pending, or, to the Company's Knowledge, threatened against, relating to or affecting the Company or any of its Subsidiaries, before any court, governmental department, commission, agency, instrumentality or regulatory or other authority, or any arbitrator that would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect or that are reasonably likely to prevent or materially impede or delay the consummation of the Offer, the Merger or any of the other transactions contemplated by this Agreement or the CVR Agreement. Neither the Company nor any of its Subsidiaries is subject to any judgment, decree, injunction, rule or order of any court, governmental department, commission, agency, instrumentality or regulatory or other authority, or any arbitrator which prohibits or could materially impair or delay the consummation of the transactions contemplated hereby or by the CVR Agreement or would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Β Β Β Β Β Β Β Β SectionΒ 4.09.Β Β Β Β Offer Documents; Proxy Statement.Β Β Β Β Neither the ScheduleΒ 14D-9 nor any information supplied by the Company for inclusion in the Offer Documents will, at the respective times that the ScheduleΒ 14D-9, the Offer Documents or any amendments or supplements thereto are filed with the SEC or are published, sent or given to stockholders of the Company, as the case may be, contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they are made, not misleading. The Proxy Statement will not, on the date the Proxy Statement (or any amendment or supplement thereto) is first mailed to stockholders of the Company, and at the time of the Company Meeting, contain any untrue statement of a material fact, or omit to state any material fact required to be stated therein or necessary in order to make the statements made therein, in the light of the circumstances under which they are made, not misleading. The ScheduleΒ 14D-9 and the Proxy Statement will, when filed by the Company with the SEC, comply as to form in all material respects with the applicable provisions of the Exchange Act and the rules and regulations thereunder. Notwithstanding the foregoing, the Company makes no representation or warranty with respect to information supplied by or on behalf of Parent or Merger Sub which is contained in any of the foregoing documents.
21
Β Β Β Β Β Β Β Β SectionΒ 4.10.Β Β Β Β No Violation of Law.Β Β Β Β Neither the Company nor any of its Subsidiaries is in violation of, or since JuneΒ 30, 2000 has violated any law, statute, order, rule, regulation, ordinance or judgment (including, without limitation, any applicable environmental law, ordinance or regulation) of any governmental or regulatory body or authority, except for violations that would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, or to result in a material liability to the Company or any of its Subsidiaries. No investigation or review by any governmental or regulatory body or authority is pending or, to the Company's Knowledge, threatened, nor has any governmental or regulatory body or authority indicated an intention to conduct the same, other than, in each case, those the outcome of which, as far as reasonably can be foreseen, would not reasonably be expected to be material to the Company and its Subsidiaries, taken as a whole, or to result in a material liability to the Company or any of its Subsidiaries. The Company and its Subsidiaries have all permits, licenses, franchises, variances, exemptions, orders and other governmental authorizations, consents and approvals necessary to conduct their businesses as presently conducted (collectively, the "Company Permits"), except for permits, licenses, franchises, variances, exemptions, orders, authorizations, consents and approvals the absence of which would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. The Company and its Subsidiaries are not in violation of the terms of any Company Permit, except for violations which would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Β Β Β Β Β Β Β Β SectionΒ 4.11.Β Β Β Β Material Contracts; Compliance With Agreements.Β Β Β Β (a)Β Neither the Company nor any of its Subsidiaries is a party to or bound by:
Β Β Β Β Β Β Β Β Β Β (i)Β Β (A) any real property lease providing for annual base rentals of $1,000,000 or more and (B)Β any operating and capital leases providing for annual rentals of $750,000 or more;
Β Β Β Β Β Β Β Β Β (ii)Β Β any agreement for the purchase of materials, supplies, goods, services, equipment or other assets providing for annual payments by the Company and/or its Subsidiaries of $1,500,000 or more;
Β Β Β Β Β Β Β Β (iii)Β Β any sales, distribution or other similar agreement providing for the sale by the Company and/or its Subsidiaries of materials, supplies, goods, services, equipment or other assets that provides for annual revenue to the Company and/or its Subsidiaries of $3,000,000 or more;
Β Β Β Β Β Β Β Β (iv)Β Β any material shareholder, partnership, joint venture, joint operating or development agreement or any other similar agreement or arrangement;
Β Β Β Β Β Β Β Β Β (v)Β Β any agreement entered into within the three-year period prior to the date of this Agreement relating to the acquisition or disposition of any material amount of assets outside the ordinary course of business or the stock of any Subsidiary or business (whether by merger, purchase or sale of stock, purchase or sale of assets or otherwise);
22
Β Β Β Β Β Β Β Β (vi)Β Β any agreement relating to the indebtedness for borrowed money or the deferred purchase price of property (in either case, whether incurred, assumed, guaranteed or secured by an asset), except any such agreement (A)Β with an aggregate outstanding principal amount not exceeding $1,000,000 and which may be prepaid on not more than 30Β days' notice without the payment of any penalty, (B)Β entered into after the date of this Agreement as permitted by SectionΒ 5.01, or (C)Β constituting inter-company receivables in its entirety.
Β Β Β Β Β Β Β (vii)Β Β any material intellectual property license or other similar agreement;
Β Β Β Β Β Β (viii)Β Β any material agency, dealer, sales representative, marketing or other similar agreement;
Β Β Β Β Β Β Β Β (ix)Β Β any agreement that limits in any material respect the freedom of the Company and/or any of its Subsidiaries to compete in any line of business or with any Person or in any area or which would so limit in any material respect the freedom of the Company and/or any of its Subsidiaries after the Closing Date; or
Β Β Β Β Β Β Β Β Β (x)Β Β any material agreement with any director or executive officer of the Company or any Subsidiary or with any "associate" or any member of the "immediate family" (as such terms are respectively defined in RulesΒ 12b-2 and 16a-1 of the Exchange Act) of any such director or executive officer.
Β Β Β Β Β Β Β Β (b)Β Β Β The Company and each of its Subsidiaries (and, to the Company's Knowledge, each other party to any such Contract) are not in breach or violation of or in default in the performance or observance of any term or provision of, and no event has occurred which, with lapse of time or action by a third party, would result in a default under, (i)Β the respective articles or certificates of incorporation, bylaws or similar organizational instruments of the Company or any of its Subsidiaries or (ii)Β any Contract to which the Company or any of its Subsidiaries is a party or by which any of them is bound or to which any of their property is subject, other than as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. Each Contract disclosed in any portion of the Company Disclosure Schedule or required to be disclosed pursuant to this Section is a valid and binding agreement of the Company or one of its Subsidiaries, as the case may be, and is in full force and effect, other than as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect. For the purposes of this Agreement, the "Company's Knowledge" means, with respect to any given action, event, occurrence, fact, information or circumstance, that any of Xxxxxx Xxxxxxx, Xxxx Xxxxxxxx, Xxxxxx Xxxx, Xxxx Xxxxxxx, Xxxx X. Xxxxxxxx, Xxxx Xxxxxx, Xxxxxxxx Xxxxx, Xxxxxx Xxxxxxx, Xxxx Xxxxxx, Xxxx Xxxx, Xxxxx Xxxxxxxx, Xxxxxx XxXxxxxx or Xxx Xxxxx had actual knowledge of that action, event, occurrence, fact, information or circumstance.
Β Β Β Β Β Β Β Β SectionΒ 4.12.Β Β Β Β Taxes.Β Β Β Β (a)Β The Company and its Subsidiaries have (i)Β duly filed with the appropriate governmental authorities all Tax Returns required to be filed by them, and such Tax Returns are true, correct and complete, and (ii)Β duly paid in full all Taxes shown as due on such Tax Returns, except in each case where the failure to file such Tax Returns or pay such
23
Tax or the failure of such Tax Returns to be true, correct and complete would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect. There are no material liens for Taxes upon any property or asset of the Company or any Subsidiary thereof, except for liens for Taxes not yet due or Taxes contested in good faith and reserved against in accordance with GAAP. There are no unresolved issues of law or fact arising out of a notice of deficiency, proposed deficiency or assessment from the Internal Revenue Service (the "IRS") or any other governmental taxing authority with respect to Taxes of the Company or any of its Subsidiaries which would reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Β Β Β Β Β Β Β Β (b)Β Β Β For purposes of this Agreement, "Tax" (including, with correlative meaning, the term "Taxes") includes all federal, state, local and foreign income, profits, franchise, gross receipts, environmental, customs duty, capital stock, communications services, severance, stamp, sales, unemployment, disability, use, property, withholding, excise, production, value added, occupancy and other taxes, duties or assessments of any nature whatsoever, together with all interest, penalties and additions imposed with respect to such amounts, and "Tax Return" means any return, report or similar statement (including attached schedules) required to be filed with respect to any Tax, including without limitation, any information return, claim for refund, amended return or declaration of estimated Tax.
Β Β Β Β Β Β Β Β (c)Β Β Β Since DecemberΒ 31, 2002, there has not been any material Tax election made or changed, any annual tax accounting period changed, any method of tax accounting adopted or changed, any material amended Tax Returns or claims for material Tax refunds filed, any material closing agreement entered into, any material Tax claim, audit or assessment settled, or any right to claim a material Tax refund, offset or other reduction in Tax liability surrendered.
Β Β Β Β Β Β Β Β SectionΒ 4.13.Β Β Β Β Employee Benefit Plans; ERISA.Β Β Β Β (a)Β SectionΒ 4.13(a) of the Company Disclosure Schedule includes a complete list of each employee benefit plan, program or policy (written or oral) providing benefits to any current or former employee, consultant, officer or director of the Company or any of its Subsidiaries or any beneficiary or dependent thereof that is sponsored, maintained, or administered by the Company or any of its ERISA Affiliates or to which the Company or any of its ERISA Affiliates contribute or is obligated to contribute (other than those programs or policies that do not provide material benefits), or with respect to which the Company or any of its ERISA Affiliates has any liability, including without limitation any employee welfare benefit plan within the meaning of SectionΒ 3(1) of ERISA, any employee pension benefit plan within the meaning of SectionΒ 3(2) of ERISA (whether or not such plan is subject to ERISA, and including any "multiemployer plan" within the meaning of SectionΒ 4001(a)(3) of ERISA (a "Multiemployer Plan")), any employee benefit plan within the meaning of SectionΒ 3(3) of ERISA, and any material compensation, bonus, profit sharing incentive, deferred compensation, vacation, insurance (including any self-insured arrangements), health or medical benefits, employee assistance, disability or sick leave benefits, workers' compensation, supplemental unemployment benefits, post-employment or retirement benefits (including compensation, pension, health, medical or life insurance benefits), stock purchase, stock option, stock based, severance, employment, change of control or fringe benefit agreement, plan, program or policy in each case, whether or not written (collectively, the "Company Employee Benefit Plans"). For purposes of this Agreement, "ERISA Affiliate" of any entity
24
means any other entity which, together with such entity, would be treated as a single employer under SectionΒ 414 of the Code.
Β Β Β Β Β Β Β Β (b)Β Β Β With respect to each Company Employee Benefit Plan, the Company has delivered or made available to Parent a true, correct and complete copy of: (i)Β all plan documents and related trust or funding agreements or insurance policies; (ii)Β the most recent Annual Report (FormΒ 5500 Series) and accompanying schedule, if any; (iii)Β the current summary plan description, if any; (iv)Β the most recent annual financial report, if any; (v)Β the most recent actuarial report, if any; and (vi)Β the most recent determination letter from the IRS, if any. Except as specifically provided in the foregoing documents, or in other documents, delivered or made available to Parent, there are no amendments to any Company Employee Benefit Plan that have been adopted or approved.
Β Β Β Β Β Β Β Β (c)Β Β Β The IRS has issued a favorable determination letter with respect to each Company Employee Benefit Plan that is intended to be a "qualified plan" within the meaning of SectionΒ 401(a) of the Code and its related trust that has not been revoked, and the Company is not aware of any circumstances or events that have occurred that would reasonably be expected to result in a revocation of such letter.
Β Β Β Β Β Β Β Β (d)Β Β Β The Company and its ERISA Affiliates have materially complied, and are now in material compliance, with all provisions of ERISA, the Code and all laws, rules and regulations applicable to each Company Employee Benefit Plan and each Company Employee Benefit Plan has been administered in all material respects in accordance with its terms. None of the Company and its ERISA Affiliates nor any other person, including any fiduciary, has engaged in any "prohibited transaction" (as defined in SectionΒ 4975 of the Code or SectionΒ 406 of ERISA), which could subject any of the Company Employee Benefit Plans or their related trusts, the Company, any of its ERISA Affiliates or any person that the Company or any of its ERISA Affiliates has an obligation to indemnify, to any tax or penalty imposed under SectionΒ 4975 of the Code or SectionΒ 502 of ERISA. There are no pending or, to the Company's Knowledge, threatened claims (other than claims for benefits in the ordinary course), lawsuits, audits, actions or arbitrations which have been asserted or instituted against the Company Employee Benefit Plans, any fiduciaries thereof with respect to their duties to the Company Employee Benefit Plans or the assets of any of the trusts under any of the Company Employee Benefit Plans which could reasonably be expected to result in any liability of the Company or any of its ERISA Affiliates to the Pension Benefit Guaranty Corporation, the Department of Treasury, the Department of Labor or any Company Employee Benefit Plan.
Β Β Β Β Β Β Β Β (e)Β Β Β Neither the execution and delivery of this Agreement or the CVR Agreement nor the consummation of the transactions contemplated hereby or thereby will entitle any employee to severance pay or result in, cause the accelerated vesting, funding or delivery of, or increase or enhance any benefit or the amount or value of, any material payment or benefit to any current or former employee, officer or director of the Company or any of its Subsidiaries, or result in any limitation on the right of the Company or any of its Subsidiaries to amend, merge, terminate or receive a reversion of assets from any Company Employee Benefit Plan or related trust.
25
Β Β Β Β Β Β Β Β (f)Β Β Β Β No Company Employee Benefit Plan is subject to Title IV or SectionΒ 302 of ERISA or SectionΒ 412 or 4971 of the Code, and none of the Company and its ERISA Affiliates, has, at any time during the last six years sponsored, maintained or contributed to or been obligated to contribute to any plan subject to Title IV of ERISA. No employees of the Company or any of its Subsidiaries located outside of the United States participate in or are eligible to participate in any Company Employee Benefit Plans providing pension or retirement benefits, and neither the Company nor any of its Subsidiaries has any liability with respect to or arising under any such plans, whether or not currently in existence or effective.
Β Β Β Β Β Β Β Β (g)Β Β Β No Company Employee Benefit Plan is a Multiemployer Plan, none of the Company and its ERISA Affiliates has, at any time during the last six years, contributed to or been obligated to contribute to any Multiemployer Plan, and none of the Company and its ERISA Affiliates has incurred any withdrawal liability to a Multiemployer Plan that has not been satisfied in full.
Β Β Β Β Β Β Β Β (h)Β Β Β Neither the Company nor any of its Subsidiaries has any obligations for or any current or projected liability in respect of post-employment or post-retirement health, medical or life benefits under any Company Employee Benefit Plan or otherwise, except for obligations under SectionΒ 601 et. seq. of ERISA and SectionΒ 4980B of the Code ("COBRA").
Β Β Β Β Β Β Β Β (i)Β Β Β Β Since DecemberΒ 31, 2002, other than in the ordinary course of business consistent with past practice, with respect to any director, executive officer (as such terms are respectively defined in RulesΒ 12b-2 and 16a-1 of the Exchange Act) or key employee (meaning an employee with the title Executive Vice President or above) of the Company or any of its Subsidiaries, there has not been any (i)Β grant of any severance or termination pay to (or amendment to any existing arrangement with), (ii)Β increase in benefits payable under any existing severance or termination pay policies or employment agreements, (iii)Β any entering into any employment, deferred compensation or other similar agreement (or any amendment to any such existing agreement), (iv)Β establishment, adoption or amendment (except as required by applicable law) of any collective bargaining, bonus, profit-sharing, thrift, pension, retirement, deferred compensation, compensation, stock option, restricted stock or other benefit plan or arrangement, or (v)Β increase in compensation, bonus or other benefits payable.
Β Β Β Β Β Β Β Β (j)Β Β Β Β There is no contract, plan or arrangement (written or otherwise) covering any employee or former employee of the Company or any of its Subsidiaries that, individually or collectively, could give rise to the payment of any amount that would not be deductible pursuant to the terms of SectionΒ 280G or 162(m) of the Code.
Β Β Β Β Β Β Β Β (k)Β Β Β Neither the Company nor any of its ERISA Affiliates has any commitment or obligation to establish or adopt any new or additional employee benefit plans or to increase the benefits under any existing Company Employee Benefit Plan.
Β Β Β Β Β Β Β Β SectionΒ 4.14.Β Β Β Β Labor Controversies.Β Β Β Β (a)Β The Company and its Subsidiaries are in compliance with all currently applicable laws respecting employment and employment practices, terms and conditions of employment and wages and hours, and are not engaged in any unfair labor practice, failure to comply with which or engagement in which, as the case may be, would reasonably be expected to have, individually or in the aggregate, a Company Material
26
Adverse Effect. (i)Β There is not pending or, to the Company's Knowledge, threatened, any labor strike, material dispute, walk-out, work stoppage, slow-down or lockout involving the Company or any of its Subsidiaries, (ii)Β there are no controversies pending or, to the Company's Knowledge, threatened between the Company or its Subsidiaries and any representatives (including unions) of any of their employees, and (iii)Β to the Company's Knowledge, there are no organizational efforts being made involving any of the presently unorganized employees of the Company or its Subsidiaries. Neither the Company nor any of its Subsidiaries is a party to or subject to, or is currently negotiating in connection with entering into, any collective bargaining agreement or other contract or understanding with a labor union or organization.
Β Β Β Β Β Β Β Β (b)Β Β Β Since DecemberΒ 31, 2002, there has not occurred and there has not been any labor dispute, other than routine individual grievances, or any activity or proceeding by a labor union or representative thereof to organize any employees of the Company or any of its Subsidiaries, which employees were not subject to a collective bargaining agreement at DecemberΒ 31, 2002, or any lockouts, strikes, slowdowns, work stoppages or threats thereof by or with respect to such employees.
Β Β Β Β Β Β Β Β SectionΒ 4.15.Β Β Β Β Environmental Matters. (a)Β (i) The Company and its Subsidiaries have conducted their respective businesses in compliance with all applicable Environmental Laws, including, without limitation, having all permits, licenses and other approvals and authorizations necessary for the operation of their respective businesses as presently conducted, (ii)Β none of the properties owned by the Company or any of its Subsidiaries contain any Hazardous Substance as a result of any activity of the Company or any of its Subsidiaries or, to the Company's Knowledge or the knowledge of any of its Subsidiaries, as a result of any other activity, in any case in amounts requiring any investigation or remediation or which may lead to any liability to the Company or any of its Subsidiaries under any applicable Environmental Laws, (iii)Β neither the Company nor any of its Subsidiaries has received any notices, demand letters or requests for information from any federal, state, local or foreign governmental entity or from any third party indicating that the Company or any of its Subsidiaries may be in violation of, or liable under, any Environmental Law in connection with the ownership or operation of their businesses or of any real property, (iv)Β there are no civil, criminal or administrative actions, suits, demands, claims, hearings, investigations or proceedings pending or threatened, against the Company or any of its Subsidiaries relating to any violation, or alleged violation, of any Environmental Law, (v)Β no Hazardous Substance has been disposed of, released or transported in violation of any applicable Environmental Law, or in a manner giving rise to any liability under Environmental Law, from or on any properties owned or operated by the Company or any of its Subsidiaries at any time and (vi)Β neither the Company, its Subsidiaries nor any of their respective properties are subject to any liabilities or expenditures (fixed or contingent) relating to any suit, settlement, court order, administrative order, regulatory requirement, judgment or claim asserted or arising under any Environmental Law, except for violations of the foregoing clauses (i)Β through (vi)Β that would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.
Β Β Β Β Β Β Β Β (b)Β Β Β As used herein, "Environmental Law" means any federal, state, local or foreign law, statute, ordinance, rule, regulation, code, license, permit, authorization, approval, consent, order, judgment, decree, injunction, requirement or agreement with any governmental entity relating to (x)Β the protection, preservation or restoration of the environment (including,
27
without limitation, air, water vapor, surface water, groundwater, drinking water supply, surface land, subsurface land, plant and animal life or any other natural resource) or to human health or safety, or (y)Β the exposure to, or the use, storage, recycling, treatment, generation, transportation, processing, handling, labeling, production, release or disposal of Hazardous Substances, in each case as amended and as in effect at the date hereof.
Β Β Β Β Β Β Β Β (c)Β Β Β As used herein, "Hazardous Substance" means any hazardous, toxic or radioactive substance or waste including, without limitation, any pollutant, contaminant, special waste, industrial substance or petroleum or any derivative or byproduct thereof, radon, asbestos, or asbestos-containing material, urea formaldehyde foam insulation or polychlorinated biphenyls.
Β Β Β Β Β Β Β Β SectionΒ 4.16.Β Β Β Β Intellectual Property. The Company and its Subsidiaries own, or are licensed to use, all Intellectual Property used in and material to the conduct of the Company's business as it is currently conducted, and the consummation of the transactions herein will not materially alter, materially impair or extinguish any of the Company's or its Subsidiaries' rights in any such Intellectual Property. To the Company's Knowledge, all material patents and patent applications, material registered trademarks, material registered trade names, material registered service marks and material registered copyrights (the "Company IP") are valid and subsisting. A true and complete list of the Company IP is provided in SectionΒ 4.16 of the Company Disclosure Schedule. To the Company's Knowledge, the Company and its Subsidiaries own or are licensed to use all Intellectual Property necessary to exploit the Company's or its Subsidiaries' projects in development that have been disclosed in the Company SEC Reports or otherwise publicly announced. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i)Β to the Company's Knowledge, the use of the Intellectual Property by the Company and its Subsidiaries does not infringe on or other otherwise violate the rights of any third party, and is in accordance in all material respects with the applicable license pursuant to which the Company acquired the right to use such Intellectual Property, (ii)Β to the Company's Knowledge, no third party is challenging, infringing on or otherwise violating any right of the Company in the Intellectual Property, and (iii)Β neither the Company nor any of its Subsidiaries has received any written notice of any offer to license, assertion of infringement, pending claim, order or proceeding with respect to any unlicensed third party Intellectual Property used in and material to the conduct of the Company's business as it is currently conducted, and to the Company's Knowledge, no Intellectual Property is being used or enforced by the Company in a manner that would reasonably be expected to result in the abandonment, cancellation or unenforceability of any Intellectual Property used in and material to the conduct of the Company's business as it is currently conducted. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company has taken reasonable and customary steps to protect its rights in its own confidential information and trade secrets, protect any confidential information provided to it by any other Person, and obtain ownership of works of authorship and inventions made by its employees, consultants and contractors and which are material to the Company's business. With respect to all computer software programs owned by the Company and material to the conduct of its business as it is currently conducted ("Company Software"), except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, and except as disclosed in SectionΒ 4.16 of the Company Disclosure Schedule: (i)Β no parties, other than the Company and its Subsidiaries, possess any current or contingent rights to license, sell, or
28
otherwise distribute products or services utilizing the Company IP or the Company Software, and (ii)Β no parties, other than the Company and its Subsidiaries, possess any current or contingent rights to any source code that is part of the Company Software. The Company has taken commercially reasonable steps to protect the Company Software from becoming infected by any computer code designed to disrupt, disable, harm, distort or otherwise impede in any material manner the normal operation of such software by or for the Company or its authorized users, or any other of the Company's associated software, firmware, hardware, computer system or network (including without limitation what are sometimes referred to as "viruses," "worms," unauthorized "time bombs," and/or unauthorized "back doors") and, to the Company's Knowledge (but without representing that any inspection has been made other than by normal use of the Company's virus detection software), the Company Software contains no such computer code, except as would not be reasonably expected to have, individually or in the aggregate, a Company Material Adverse Effect. For purposes of this Agreement, the term "Intellectual Property" means all patents, trademarks, trade names, service marks, copyrights, and any applications therefor, technology, know-how, computer software programs or applications, and tangible or intangible proprietary information or materials.
Β Β Β Β Β Β Β Β SectionΒ 4.17.Β Β Β Β Opinion of Financial Advisor. The Company's financial advisor, Xxxxxxx XxxxxΒ & Company (the "Company Financial Advisor"), has delivered to the Board of Directors of the Company an oral opinion, to be confirmed in writing, to the effect that, as of the date of this Agreement, the consideration to be received by the Company's stockholders in the Offer and the Merger is fair to such holders from a financial point of view.
Β Β Β Β Β Β Β Β SectionΒ 4.18.Β Β Β Β Brokers and Finders. There is no obligation on the part of the Company or any of its Subsidiaries to pay any investment banking fees, finder's fees, brokerage or agent commissions or other like payments in connection with the transactions contemplated hereby, other than fees payable to the Company Financial Advisor pursuant to a fee agreement. The calculation of such fee is set forth on SectionΒ 4.18 of the Company Disclosure Schedule.
Β Β Β Β Β Β Β Β SectionΒ 4.19.Β Β Β Β Insurance. All material fire and casualty, general liability, business interruption, directors' and officers', product liability, and sprinkler and water damage insurance policies maintained by the Company or any of its Subsidiaries are with reputable insurance carriers, provide full and adequate coverage for all normal risks incident to the business of the Company and its Subsidiaries and their respective properties, businesses and assets.
Β Β Β Β Β Β Β Β SectionΒ 4.20.Β Β Β Β Takeover Statutes. The Board of Directors of the Company has taken all actions necessary to exempt the Offer, the Top-Up Option, the Merger, this Agreement and the other transactions contemplated hereby under SectionΒ 203 of the DGCL. No other state takeover or similar statute or regulation is applicable to this Agreement, the CVR Agreement, the Offer, the Top-Up Option, the Merger or the other transactions contemplated hereby or thereby.
Β Β Β Β Β Β Β Β SectionΒ 4.21.Β Β Β Β Receivables and Customers. Except as would not reasonably be expected to have, whether individually or in the aggregate, a Company Material Adverse Effect:
Β Β Β Β Β Β Β Β (a)Β Β Β All accounts, notes receivable and other receivables (other than receivables collected since MarchΒ 31, 2003) reflected on the consolidated balance sheet of the
29
Company as of that date that is contained in the Company 10-Q are, and all accounts, notes and other receivables arising from or otherwise relating to the business of the Company and its Subsidiaries since that date will be, valid, genuine and fully collectible in the aggregate amount thereof, subject to normal and customary trade discounts, less any reserves for doubtful accounts recorded on that balance sheet.
Β Β Β Β Β Β Β Β (b)Β Β Β All accounts, notes receivable and other receivables arising out of or relating to the business of the Company and its Subsidiaries as of MarchΒ 31, 2003 have been included in the consolidated balance sheet of the Company as of that date that is contained in the Company 10-Q in accordance with generally accepted accounting principles applied on a consistent basis.
Β Β Β Β Β Β Β Β (c)Β Β Β Since DecemberΒ 31, 2002, there has not been any termination, cancellation or curtailment of the business relationship of the Company or any of its Subsidiaries with any customer or group of affiliated customers (nor has any such customer or group been subject to any voluntary or involuntary bankruptcy or similar filing under applicable law since that date), and neither the Company nor any of its Subsidiaries has received any written notice of an intent to so terminate, cancel or curtail.
ARTICLE V
COVENANTS
Β Β Β Β Β Β Β Β SectionΒ 5.01.Β Β Β Β Conduct of Business Pending the Merger.Β Β Β Β Except as otherwise expressly contemplated by this Agreement, required by law or disclosed in SectionΒ 5.01 of the Company Disclosure Schedule, after the date hereof and prior to the Effective Time, without Parent's consent (which shall not be unreasonably withheld), the Company shall, and shall cause its Subsidiaries to:
Β Β Β Β Β Β Β Β (a)Β Β Β conduct their respective businesses in the ordinary and usual course of business and consistent with past practice;
Β Β Β Β Β Β Β Β (b)Β Β Β not (i)Β amend or propose to amend their respective certificates of incorporation or bylaws or equivalent constitutional documents, (ii)Β split, combine or reclassify their outstanding capital stock or (iii)Β declare, set aside or pay any dividend or distribution payable in cash, stock, property or otherwise, except for the payment of dividends or distributions to the Company or a Subsidiary of the Company by another Subsidiary of the Company;
Β Β Β Β Β Β Β Β (c)Β Β Β not issue, sell, pledge or dispose of, or agree to issue, sell, pledge or dispose of, any additional shares of, or any options, warrants or rights of any kind to acquire any shares of their capital stock of any class or any debt or equity securities convertible into or exchangeable for such capital stock, except that the Company may issue shares of capital stock of the Company (A)Β upon exercise of Company Options outstanding on MayΒ 31, 2003 and (B)Β as required by the 401(k) Plan, the ESPP, the Directors' Plan, the DCP and the Company Rights Agreement as in effect on the date hereof;
30
Β Β Β Β Β Β Β Β (d)Β Β Β not (i)Β incur or become contingently liable with respect to any indebtedness for borrowed money (including, for the sake of clarity, any letters of credit), other than borrowings in the ordinary course of business or borrowings to fund working capital needs in the ordinary course of business under the existing credit facilities of the Company or any of its Subsidiaries on the terms of those facilities as they exist on the date of this Agreement (the "Existing Credit Facilities") in an aggregate amount for all such permitted borrowings not to exceed $20,000,000 for any consecutive four business day period, (ii)Β redeem, purchase, acquire or offer to purchase or acquire any shares of its capital stock or any options, warrants or rights to acquire any of its capital stock or any security convertible into or exchangeable for its capital stock other than in connection with the exercise of outstanding Company Options pursuant to the terms of the Company Option Plans and the relevant written agreements evidencing the grant of Company Options, or to use for the 401(k) Plan, the ESPP or the Directors' Plan, (iii)Β make any material acquisition of any assets or businesses other than expenditures for current assets in the ordinary course of business and expenditures for fixed or capital assets in the ordinary course of business with a value that is less than (A)Β $2,500,000 in the aggregate during the forty-five (45)Β day period commencing on the date of this Agreement and (B)Β $4,500,000 in the aggregate during the ninety (90)Β day period commencing on the date of this Agreement or (iv)Β sell, pledge, lease, license dispose of or encumber any material assets or businesses other than (A)Β any such transactions disclosed in SectionΒ 5.01 of the Company Disclosure Schedule, (B)Β pledges or encumbrances pursuant to Existing Credit Facilities or (C)Β sales of inventory and other current assets in the ordinary course of business consistent with past practices.
Β Β Β Β Β Β Β Β (e)Β Β Β use reasonable best efforts to preserve intact their respective business organizations and goodwill, keep available the services of their respective present officers and key employees (other than terminations of services for cause), and preserve the goodwill and business relationships with customers and others having business relationships with them;
Β Β Β Β Β Β Β Β (f)Β Β Β Β not enter into or amend or modify any employment, consulting, severance, retirement or special pay arrangement with respect to termination of employment or other similar arrangements or agreements with any directors, officers or key employees or with any other persons, except (i)Β as required by previously existing contractual arrangements or applicable law or (ii)Β other employment agreements entered into with a person who is hired or promoted by the Company or one of its Subsidiaries after the date hereof in the ordinary course of business whose annual base salary does not exceed $175,000;
Β Β Β Β Β Β Β Β (g)Β Β Β not increase the salary, bonus, benefits or other compensation of any person except for increases in the ordinary course of business consistent with past practice or except pursuant to contractual arrangements existing on the date of this Agreement;
Β Β Β Β Β Β Β Β (h)Β Β Β not adopt, enter into or amend or modify, in each of the latter two cases to materially increase benefits or obligations of any Company Employee Benefit Plan, except as required pursuant to existing contractual arrangements, this Agreement or applicable law;
Β Β Β Β Β Β Β Β (i)Β Β Β Β (A) not enter into any new contract or commitment providing for the purchase of goods or services by the Company or any of its Subsidiaries that is inconsistent with the Company's AprilΒ 2003 forecast (a true, accurate, complete and current copy of which has been provided to Parent prior to the date of this Agreement) or has a term of more than one year
31
and which is reasonably expected to involve payments to retailers of more than $3,000,000 per annum or payments to other third parties of more than $2,000,000 per annum, (B)Β not amend, modify or change in any material respect, or waive any material rights of the Company or any of its Subsidiaries or any material obligation of any third party under, any contract listed in SectionΒ 4.11 of the Company Disclosure Schedule;
Β Β Β Β Β Β Β Β (j)Β Β Β Β not make, change or revoke any material Tax election unless required by law or make any agreement or settlement with any taxing authority regarding any material amount of Taxes or which is reasonably likely to materially increase the obligations of the Company or the Surviving Corporation to pay Taxes in the future;
Β Β Β Β Β Β Β Β (k)Β Β Β not defer the payment of accounts or trade payables, or seek to accelerate the payment of, or factor or otherwise similarly monetize, accounts or trade receivables, of the Company or any of its Subsidiaries, in either such case beyond or in advance (as the case may be) of the customary payment periods of the Company, such Subsidiary(ies) or such third parties for those payables or receivables;
Β Β Β Β Β Β Β Β (l)Β Β Β Β not enter into any interest rate, currency or other swap or derivative transaction, other than in the ordinary course of business consistent with past practices and for bona fide hedging purposes;
Β Β Β Β Β Β Β Β (m)Β Β not take any action that would make any representation or warranty of the Company inaccurate in any material respect at any time before the Effective Time;
Β Β Β Β Β Β Β Β (n)Β Β Β not (i)Β propose or make, or engage in any discussions or negotiations with respect to, any Settlement Decision (as defined in the CVR Agreement) or (ii)Β enter into any confidentiality agreement with any third party to the Litigation (as defined in the CVR Agreement) with respect thereto; or
Β Β Β Β Β Β Β Β (o)Β Β Β not enter into an agreement, commitment or arrangement with respect to any of the foregoing.
Β Β Β Β Β Β Β Β SectionΒ 5.02.Β Β Β Β Restrictions on Parent and the Company.Β Β Β Β (a)Β Parent agrees that, from and after the date hereof and prior to the Acceptance Date, and except as may be agreed in writing by the Company or as may be expressly permitted pursuant to this Agreement (including the exercise of termination rights under this Agreement), Parent shall not, and shall not permit any of its Subsidiaries to agree, in writing or otherwise, to take any action which would materially delay the consummation of the Offer, including by application of RuleΒ 14e-5 under the Exchange Act.
Β Β Β Β Β Β Β Β (b)Β Β Β The Company agrees that, from and after the date hereof and prior to the Acceptance Date, and except as may be agreed in writing by Parent or as may be expressly permitted pursuant to this Agreement (including any actions pursuant to SectionΒ 5.03 and including the exercise of termination rights under this Agreement), the Company shall not, and shall not permit any of its Subsidiaries to agree, in writing or otherwise, to take any action which would materially delay the consummation of the Offer.
32
Β Β Β Β Β Β Β Β SectionΒ 5.03.Β Β Β Β No Solicitation.Β Β Β Β (a)Β The Company shall not and shall not permit its Subsidiaries or any officer, director, employee, attorney, accountant, investment banker, financial advisor or other agent retained by it or any of its Subsidiaries to, directly or indirectly, (i)Β solicit, initiate or take any action to facilitate or knowingly encourage the submission of any Acquisition Proposal, (ii)Β enter into or participate in any discussions or negotiations with, or furnish any information relating to the Company or any of its Subsidiaries or afford access to the business, properties, assets, books or records of the Company or any of its Subsidiaries to, any Third Party that is seeking to make or has made an Acquisition Proposal, (iii)Β grant any waiver or release under any standstill or similar agreement with respect to any class of equity securities of the Company or any of its Subsidiaries or (iv)Β enter into any agreement with respect to an Acquisition Proposal, unless the Company shall have terminated this Agreement in compliance with SectionΒ 7.01(d). For purposes of this Agreement, the term, "Acquisition Proposal" means any proposal or offer (other than any proposal or offer by Parent or any of its Subsidiaries) to acquire all or 15% or more of the business, properties or capital stock of the Company or any of its Subsidiaries, whether by merger, purchase of assets, tender offer or otherwise, whether for cash, securities or any other consideration or combination thereof, other than any transaction involving Parent or any of its Subsidiaries.
Β Β Β Β Β Β Β Β (b)Β Β Β Notwithstanding the provisions of paragraphΒ (a) above or any other provision of this Agreement, subject to compliance with SectionΒ 5.03(c), the Company may, in response to an unsolicited bona fide written Acquisition Proposal from any Person or group (a "Potential Acquiror") which the Company's Board of Directors determines, in good faith and after consultation with its independent financial advisor and legal counsel, could reasonably be expected to lead to a Superior Proposal, furnish confidential or nonpublic information pursuant to a confidentiality agreement with terms no less favorable to the Company than those contained in the Confidentiality Agreement to, and engage in discussions and negotiate with, such Potential Acquiror, provided that the Company Board of Directors determines in good faith after consultation with outside legal counsel, that such action is necessary in order for its directors to comply with their fiduciary duties under applicable law. For purposes of this Agreement, "Superior Proposal" means an unsolicited bona fide written Acquisition Proposal for at least a majority of the voting power of the shares of the Company Common Stock then outstanding or all or substantially all of the assets of the Company and its Subsidiaries which the Company's Board of Directors determines, in good faith and after consultation with its independent financial advisor and outside legal counsel, would be more favorable to and provide consideration to the holders of Company Common Stock with greater financial value than the consideration payable in the Offer and the Merger, taking into account all the terms and conditions of the Acquisition Proposal, including any break-up fees, expense reimbursement provisions and conditions to consummation and for which financing is then fully committed; provided that, for the sake of clarity, an Acquisition Proposal shall only be deemed to have been solicited for purposes of this definition as a result of actions taken on or after the date of this Agreement, and not as a result of any actions taken before the date of this Agreement (for example, and by way of illustration, in connection with the auction of the Company to other prospective bidders before the date hereof). The Company agrees that it will immediately cease and cause to be terminated any existing activities, discussions or negotiations with any parties conducted heretofore with respect to any Acquisition Proposal. The Company shall also use its reasonable best efforts to cause any such party (or its agents or advisors) in possession of confidential information about the Company or any of its Subsidiaries that was furnished by or on behalf of the Company to return or destroy all
33
of that information. The Company agrees that it will take the necessary steps to promptly inform the individuals or entities referred to in SectionΒ 5.03(a) that have been engaged in connection with the evaluation of a possible Acquisition Transaction of the obligations undertaken in this SectionΒ 5.03.
Β Β Β Β Β Β Β Β (c)Β Β Β The Company shall promptly (but in no event later than 24Β hours) notify Parent after receipt by it, any of its Subsidiaries or any of their respective advisors of any Acquisition Proposal, any communication (whether written or oral) from any Potential Acquiror or its advisor that such Potential Acquiror is considering making an Acquisition Proposal or any request for information relating to the Company or any of its Subsidiaries or for access to the business, properties, assets, books or records of the Company or any of its Subsidiaries by any Potential Acquiror that may be considering making or has made an Acquisition Proposal. Such notice to Parent shall be made orally and in writing and shall indicate in reasonable detail the identity of the offeror and the material terms and conditions of such proposal, to the extent known. The Company shall thereafter keep Parent informed, on a reasonably current basis, on the status and terms of any such Acquisition Proposal and the status of any discussion or negotiations with any Potential Acquiror related thereto.
Β Β Β Β Β Β Β Β (d)Β Β Β Notwithstanding SectionΒ 5.03(a), following receipt of a Superior Proposal and after providing written notice to Parent at least three business days before doing so, the Board of Directors of the Company may withdraw or modify (or alter or modify in a manner adverse to Parent) the recommendation by the Board of Directors of the Company of this Agreement, the Offer or the Merger, if the Board of Directors of the Company determines in good faith (after consultation with its outside counsel) that its fiduciary obligations require it to do so.
Β Β Β Β Β Β Β Β (e)Β Β Β Nothing contained in this SectionΒ 5.03 or any other provision of this Agreement shall prohibit the Company or the Board of Directors of the Company from taking and disclosing to the Company's stockholders a position with respect to a tender or exchange offer by a third party pursuant to RuleΒ 14d-9 and 14e-2 promulgated under the Exchange Act.
Β Β Β Β Β Β Β Β SectionΒ 5.04.Β Β Β Β Access to Information; Confidentiality.Β Β Β Β Subject to applicable law, the Company and its Subsidiaries shall afford to Parent, Merger Sub and their financing sources and their respective accountants, counsel, financial advisors and other representatives (the "Parent Representatives") reasonable access during normal business hours upon reasonable notice throughout the period prior to the Effective Time to their respective properties, books, contracts, commitments and records and, during such period, shall furnish promptly such information concerning its businesses, properties and personnel as Parent or Merger Sub shall reasonably request; provided, however, such investigation shall not unreasonably disrupt the Company's operations. All nonpublic information provided to, or obtained by, Parent, Merger Sub or any such financing source in connection with the transactions contemplated hereby shall be "Confidential Information" for purposes of the Confidentiality Agreement dated FebruaryΒ 19, 2003 between Parent and the Company (the "Confidentiality Agreement"), the terms of which shall continue in force until the Effective Time; provided that Parent, Merger Sub and the Company may disclose such information as may be necessary in connection with seeking the Parent Required Statutory Approvals and the Company Required Statutory Approvals. Notwithstanding the foregoing, the Company shall not be required to provide any information
34
which it reasonably believes it may not provide to Parent by reason of applicable law, rules or regulations, which constitutes information protected by attorney/client privilege, or which the Company or any Subsidiary is required to keep confidential by reason of contract, agreement or understanding with third parties; provided that, with respect to any such information, the Company shall, or shall cause the relevant Subsidiary to, provide the maximum amount of that information (or shall endeavor to otherwise convey that information in a manner) that is consistent with the applicable law, rule or regulation, the maintenance of that privilege or the terms of the relevant contract, as applicable. No investigation pursuant to this SectionΒ 5.04(a) shall affect or be deemed to modify any representation or warranty in this Agreement of any party hereto or any condition to the obligations of the parties hereto. Notwithstanding anything herein to the contrary, any party to this Agreement (and each employee, representative, or other agent of such parties) may disclose to any and all persons, without limitation of any kind, the U.S. "tax treatment" or "tax structure" (in each case, within the meaning of Treasury Regulation sectionΒ 1.6011-4) of the transactions contemplated hereunder and all materials of any kind (including opinions or other tax analysis, but without disclosure of identifying information or, except to the extent relating to such U.S. "tax treatment" or "tax structure," any non-public commercial or financial information) that are provided to such parties relating to such U.S. "tax treatment" and "tax structure" (in each case, within the meaning of Treasury Regulation sectionΒ 1.6011-4); provided, that such disclosure may not be made until the earlier of (x)Β the date of public announcement of discussions relating to the transactions contemplated by this Agreement, (y)Β the date of the public announcement of the transactions contemplated by this Agreement, or (z)Β the date of execution of this Agreement. Moreover, notwithstanding anything herein to the contrary, there shall be no limitation on any party's ability to consult any tax adviser, whether or not independent from the parties, regarding the U.S. "tax treatment" or "tax structure" of the transactions contemplated by this Agreement. The intent of this provision is that the transactions contemplated by the Agreement are not treated as having been offered under conditions of confidentiality for purposes of Treasury Regulation sectionΒ 1.6011-4(b)(3) and shall be construed in a manner consistent with such purpose.
Β Β Β Β Β Β Β Β SectionΒ 5.05.Β Β Β Β Merger Sub.Β Β Β Β Parent will take all action necessary (a)Β to cause Merger Sub to perform its obligations under this Agreement and to consummate the Merger on the terms and conditions set forth in this Agreement and (b)Β to ensure that, prior to the Effective Time, Merger Sub shall not conduct any business or make any investments other than as specifically contemplated by or in furtherance of this Agreement, or incur or guarantee any indebtedness other than as necessary for the consummation of the transaction contemplated hereby.
Β Β Β Β Β Β Β Β SectionΒ 5.06.Β Β Β Β Employee Benefits.Β Β Β Β (a)Β Until DecemberΒ 31, 2004, Parent shall provide, or shall cause to be provided, to each employee of the Company and its Subsidiaries, who is an employee thereof as of the Acceptance Date (the "Company Employees") cash compensation and employee benefits that are substantially comparable, in the aggregate, to those provided to Company Employees immediately before the Acceptance Date (excluding benefits provided under any plan, program or policy providing severance or termination benefits and benefits provided under any stock option or other stock-based plan, program or policy). The foregoing shall not be construed to prevent the termination of employment of any Company Employee or the amendment or termination of any particular Company Employee Benefit Plan to the extent permitted by its terms and under any applicable law.
35
Β Β Β Β Β Β Β Β (b)Β Β Β For purposes of eligibility and vesting and levels of benefits under the employee benefit plans of Parent and its Affiliates providing benefits to any Company Employees after the Acceptance Date (the "New Plans"), each Company Employee shall be credited with his or her years of service with the Company and its Affiliates before the Acceptance Date, to the same extent as such Company Employee was entitled, before the Acceptance Date, to credit for such service under any corresponding Company Employee Benefit Plans in which such employee participated, except to the extent such credit would result in a duplication of benefits. In addition, and without limiting the generality of the foregoing: (i)Β each Company Employee shall be immediately eligible to participate, without any waiting time, in any and all New Plans to the extent coverage under such New Plan replaces coverage under a comparable Company Employee Benefit Plan in which such Company Employee participated immediately before the Acceptance Date; and (ii)Β for purposes of each New Plan providing medical, dental, pharmaceutical and/or vision benefits to any Company Employee, Parent shall cause all pre-existing condition exclusions and actively-at-work requirements of such New Plan to be waived for such employee and his or her covered dependents to the extent such exclusions or requirements were not applicable under the corresponding Company Employee Benefit Plan in which such employee participated, and Parent shall cause any eligible expenses incurred by such employee and his or her covered dependents during the portion of the plan year of the Company Employee Benefit Plan ending on the date such employee's participation in the corresponding New Plan begins to be taken into account under such New Plan for purposes of satisfying all deductible, coinsurance and maximum out-of-pocket requirements applicable to such employee and his or her covered dependents for the applicable plan year to the extent that those expenses were incurred during a period in which the employee or covered dependent was covered under a corresponding Company Employee Benefit Plan.
Β Β Β Β Β Β Β Β (c)Β Β Β Prior to and as of the Acceptance Date, the Company shall terminate each Company Option Plan, the DCP, the Directors' Plan, the ESPP, the 1999 Restricted Stock Plan and each other Company Employee Benefit Plan providing for the grant of stock-based awards or under which grants of stock-based awards have been made. The Company shall freeze the ESPP effective JulyΒ 1, 2003 so that a new Accumulation Period under the ESPP does not begin on JulyΒ 1, 2003. The Company shall not take any action to set or otherwise commence a new Accumulation Period or Exercise Date (each as defined in the ESPP) unless this Agreement shall have been terminated in accordance with ArticleΒ VII hereof.
Β Β Β Β Β Β Β Β (d)Β Β Β Prior to the Acceptance Date, the Company shall cause all shares of Company Common Stock that are then held in the Unallocated Stock Account (as such term is defined in the DCP) under the DCP to be allocated, or reallocated, as the case may be, to Stock Accounts (as such term is defined in the DCP) under the DCP.
Β Β Β Β Β Β Β Β (e)Β Β Β With respect to the Directors' Plan, the Company shall distribute shares of Company Common Stock payable for services rendered in second quarter 2003 and that portion of the third quarter 2003 ending on the Payment Date (as defined below) by participants in such plan on the date (the "Payment Date") that is the earlier of (i)Β AugustΒ 1, 2003 and (ii)Β the day that is immediately prior to the Acceptance Date.
Β Β Β Β Β Β Β Β (f)Β Β Β Β No provision of this SectionΒ 5.06 shall create any third party beneficiary or other rights in any employee or former employee (including any beneficiary or dependent
36
thereof) of the Company or any of its Affiliates in respect of continued employment with, or any benefits which may be provided by, either Parent or any of its Affiliates.
Β Β Β Β Β Β Β Β SectionΒ 5.07.Β Β Β Β Proxy Statement.Β Β Β Β As promptly as practicable after the consummation of the Offer and if required by the Exchange Act, the Company shall prepare and file with the SEC, and shall use all reasonable efforts to have cleared by the SEC, and promptly thereafter shall mail to stockholders, the Proxy Statement. Parent and Merger Sub agree to cooperate with the Company in the preparation of the Proxy Statement and other proxy solicitation materials of the Company. The Company shall provide Parent and its counsel with a reasonable opportunity to review the draft Proxy Statement each time before it is filed with the SEC and shall give reasonable and good faith consideration to any comments from Parent and its counsel on such draft(s). The Proxy Statement shall contain the recommendation of the Company's Board of Directors that the Company's stockholders approve and adopt this Agreement and the Merger, unless the fiduciary duties of the Company's Board of Directors require that the Board withdraw or adversely alter or modify that recommendation or that the Board recommend against approval and adoption. Unless this Agreement is previously terminated in accordance with SectionΒ 7.01, the Company shall, if required, submit this Agreement to its stockholders at the Company Meeting, even if the Board of Directors of the Company determines at any time after the date of this Agreement that it is no longer advisable, adversely alters its recommendation or recommends that the Company stockholders reject it. The Company shall promptly provide Parent and its counsel in writing with any written comments (and orally, any oral comments) that the Company or its counsel may receive from the SEC or its staff with respect to the Proxy Statement promptly after the receipt of those comments and shall consult with (and shall duly consider in good faith any comments of) Parent and its counsel before responding to those comments. The Company and its counsel will provide Parent and its counsel with a reasonable opportunity to participate in all communications, if any, with the SEC and its staff, including any meetings and telephone conferences relating to the Proxy Statement, this Agreement, the CVR Agreement or the matters or transactions contemplated hereby or thereby.
Β Β Β Β Β Β Β Β SectionΒ 5.08.Β Β Β Β Company Meeting.Β Β Β Β Following the consummation of the Offer, the Company shall promptly take all action necessary in accordance with the DGCL and its Certificate of Incorporation and By-Laws to convene the Company Meeting, if such meeting is required, as soon as reasonably practicable. The stockholder vote required for approval of the Merger will be no greater than that set forth in the DGCL. The Company shall use its reasonable efforts to solicit from stockholders of the Company proxies in favor of the Merger and shall take all other action necessary or, in the reasonable opinion of Parent, advisable to secure any vote of stockholders required by the DGCL to effect the Merger. Notwithstanding the foregoing, if Parent, Merger Sub or any other subsidiary of Parent shall acquire at least 90Β percent of the outstanding shares of Company Common Stock, and provided that the conditions set forth in ArticleΒ VI shall have been satisfied or waived, the Company shall, at the request of Parent, take all necessary and appropriate action to cause the Merger to become effective as soon as practicable after such acquisition, without the approval of the stockholders of the Company, in accordance with SectionΒ 253 of the DGCL. Parent shall vote, or shall cause to be voted, all of the shares of Company Common Stock acquired in the Offer or otherwise owned by it or any of its Subsidiaries (including Merger Sub) in favor of the approval and adoption of this Agreement and the Merger.
37
Β Β Β Β Β Β Β Β SectionΒ 5.09.Β Β Β Β Public Announcements.Β Β Β Β Parent and the Company will consult with each other before issuing any press release or making any public statement with respect to this Agreement, the CVR Agreement or the transactions contemplated hereby or thereby and, except as may be required by applicable law or any listing agreement with NASDAQ, will not issue any such press release or make any such public statement prior to such consultation; provided that, if the Company, any Subsidiary or any of their respective directors, officers, employees or advisors receives an offer or proposal from any third party to the Litigation (as defined in the CVR Agreement) with respect to any Settlement Decision (whether or not conditional), then Parent shall have the right, in its discretion, to publicize the terms and conditions of that offer or proposal.
Β Β Β Β Β Β Β Β SectionΒ 5.10.Β Β Β Β Expenses and Fees.Β Β Β Β All costs and expenses incurred in connection with this Agreement and the CVR Agreement and the transactions contemplated hereby and thereby shall be paid by the party incurring such expenses, except that those expenses incurred in connection with printing and filing the Offer Documents, the ScheduleΒ 14D-9 and the Proxy Statement shall be equally borne by Parent and the Company.
Β Β Β Β Β Β Β Β SectionΒ 5.11.Β Β Β Β Agreement to Cooperate.Β Β Β Β (a)Β Subject to the terms and conditions of this Agreement and applicable law, Parent and the Company shall use their respective best efforts (but without the obligation on the part of any party to pay any money, to divest, sell or hold separate any assets or agree to any behavioral modifications with any Governmental Agency) to take, or cause to be taken, all actions and do, or cause to be done, all things necessary, proper or advisable under applicable laws and regulations to consummate and make effective the transactions contemplated by this Agreement, including to obtain all necessary or appropriate waivers, consents or approvals of third parties required in order to preserve contractual relationships of Parent and the Company and their respective Subsidiaries, all necessary or appropriate waivers, consents and approvals to effect all necessary registrations, filings and submissions and to lift any injunction or other legal bar to consummation of the Offer or the Merger (and, in such case, to proceed with the consummation of the Offer and the Merger as expeditiously as possible), including through all possible appeals.
Β Β Β Β Β Β Β Β (b)Β Β Β In addition to and without limitation of the foregoing, each of Parent and the Company undertakes and agrees to file (and Parent agrees to cause any Person that may be deemed to be the ultimate parent entity or otherwise to control Parent to file, if such filing is required by law) as soon as practicable, (x)Β if required by the HSR Act, a Notification and Report Form under the HSR Act with the United States Federal Trade Commission and the Antitrust Division of the United States Department of Justice (and shall file as soon as practicable any form or report required by any other Governmental Agency relating to antitrust matters) and (y)Β any and all filings that may be required to be made under Foreign Antitrust Laws in respect of this Agreement, the CVR Agreement or any transaction contemplated hereby or thereby. Each of Parent and the Company shall (and Parent shall cause any such parent entity to) (i)Β respond as promptly as practicable to any inquiries or requests received from any domestic or foreign government or governmental agency or authority (each, a "Governmental Agency") for additional information or documentation, and (ii)Β not extend any waiting period under the HSR Act (if deemed to apply to the transactions contemplated hereby) or enter into any agreement with any Governmental Agency not to consummate the transactions contemplated by this Agreement, except with the prior consent of the other parties hereto (which shall not be
38
unreasonably withheld or delayed). Each party shall (i)Β promptly notify the other party of any written communication to that party or its Affiliates from any Governmental Agency and, subject to applicable law, permit the other party to review in advance any proposed written communication to any of the foregoing; (ii)Β not participate, or to permit its Affiliates to participate, in any substantive meeting or discussion with any Governmental Agency in respect of any filings, investigation or inquiry concerning this Agreement, the CVR Agreement, the Offer or the Merger unless it consults with the other party in advance and, to the extent permitted by such Governmental Agency, gives the other party the opportunity to attend and participate thereat; and (iii)Β to the extent permitted under applicable law, furnish the other party with copies of all correspondence, filings, and communications (and memoranda setting forth the substance thereof) between them and their Affiliates and their respective representatives on the one hand, and any government or regulatory authority or members or their respective staffs on the other hand, with respect to this Agreement, the CVR Agreement, the Offer and the Merger.
Β Β Β Β Β Β Β Β SectionΒ 5.12.Β Β Β Β Directors' and Officers' Indemnification.Β Β Β Β (a)Β The indemnification provisions of the Company's Certificate of Incorporation or Bylaws as in effect at the Acceptance Date shall not be amended, repealed or otherwise modified for a period of six years from the Effective Time in any manner that would adversely affect the rights thereunder of individuals who at or prior to the Effective Time were directors, officers, employees or agents of the Company with respect to matters arising or events occurring before the Effective Time. From and after the Acceptance Date, Parent shall assume, be jointly and severally liable for, and honor, guaranty and stand surety for, and shall cause the Company to honor, in accordance with their respective terms, each of the covenants contained in this SectionΒ 5.12.
Β Β Β Β Β Β Β Β (b)Β Β Β From and after the Acceptance Date, each of Parent and the Company and, from and after the Effective Time, the Surviving Corporation shall, to the fullest extent permitted under applicable law, indemnify and hold harmless each present and former director, officer, employee and agent of the Company or any of its Subsidiaries (each, together with such person's heirs, executors or administrators, an "Indemnified Party" and collectively, the "Indemnified Parties") against any costs or expenses (including advancing attorneys' fees and expenses in advance of the final disposition of any claim, suit, proceeding or investigation to each Indemnified Party to the fullest extent permitted by law), judgments, fines, losses, claims, damages, liabilities and amounts paid in settlement in connection with any actual or threatened claim, action, suit, proceeding or investigation, whether civil, criminal, administrative or investigative, arising out of, relating to or in connection with any action or omission occurring or alleged to occur prior to the Effective Time (including, without limitation, acts or omissions in connection with such persons serving as an officer, director or other fiduciary in any entity if such service was at the request or for the benefit of the Company) or the Merger or the other transactions contemplated by this Agreement or arising out of or pertaining to the transactions contemplated by this Agreement to the fullest extent that the Company would have been permitted under Delaware law and the Company's Certificate of Incorporation and By-laws in effect on the date of this Agreement.
Β Β Β Β Β Β Β Β (c)Β Β Β For a period of six years after the Effective Time, Parent shall cause to be maintained in effect the current policies of directors' and officers' liability insurance maintained by the Company and its Subsidiaries (provided that Parent may substitute therefor policies of at least the same coverage and amounts containing terms and conditions that are no less
39
advantageous to the Indemnified Parties, and which coverages and amounts shall be no less than the coverages and amounts provided at that time for Parent's directors and officers) with respect to matters arising on or before the Effective Time; provided, however, that if the existing current policies expire, are terminated or cancelled during such six-year period, Parent will use its reasonable efforts to obtain as much coverage as can be obtained for the remainder of such period for a premium not in excess of the amount set forth in SectionΒ 5.12 of the Company Disclosure Schedules.
Β Β Β Β Β Β Β Β (d)Β Β Β Parent shall pay all reasonable expenses, including reasonable attorneys' fees, that may be incurred by any Indemnified Party in enforcing the indemnity and other obligations provided in this SectionΒ 5.12.
Β Β Β Β Β Β Β Β (e)Β Β Β The rights of each Indemnified Party hereunder shall be in addition to, and not in limitation of, any other rights such Indemnified Party may have under the Certificate of Incorporation or Bylaws of the Company, any other indemnification arrangement, the DGCL or otherwise. The provisions of this SectionΒ 5.12 shall survive the consummation of the Merger and expressly are intended to benefit each of the Indemnified Parties.
Β Β Β Β Β Β Β Β SectionΒ 5.13.Β Β Β Β SectionΒ 16 Matters.Β Β Β Β Prior to the Acceptance Date, Parent and the Company shall take all such steps as may be required and permitted to cause the transactions contemplated by this Agreement, including any dispositions of shares of Company Common Stock (including derivative securities with respect to shares of Company Common Stock) by each individual who is or will be subject to the reporting requirements of SectionΒ 16(a) of the Exchange Act with respect to the Company to be exempt under RuleΒ 16b-3 promulgated under the Exchange Act.
Β Β Β Β Β Β Β Β SectionΒ 5.14.Β Β Β Β Further Assurances.Β Β Β Β (a)Β Each party hereby agrees to perform any further acts and to execute and deliver any documents which may be reasonably necessary to carry out the provisions of this Agreement. At and after the Effective Time, the officers and directors of the Surviving Corporation shall be authorized to execute and deliver, in the name and on behalf of the Company or Merger Subsidiary, any deeds, bills of sale, assignments or assurances and to take and do, in the name and on behalf of the Company or Merger Subsidiary, any other actions and things to vest, perfect or confirm of records or otherwise in the Surviving Corporation any and all right, title and interest in, to and under any of the rights, properties or assets of the Company acquired or to be acquired by the Surviving Corporation as a result of, or in connection with, the Merger.
Β Β Β Β Β Β Β Β (b)Β Β Β Upon Parent's request, the Company shall, and shall cause its Subsidiaries and its and their respective officers and employees to provide all customary assistance, cooperation and support that Parent may reasonably request in order to assist in raising private bank or mezzanine debt financing for the Company, Parent or Merger Sub (which financing shall, for the sake of clarity, be conditioned upon the Closing); provided that (i)Β such assistance, cooperation and support shall not unreasonably disrupt the Company's operations, (ii)Β any such assistance, cooperation and support shall be at Parent's expense and (iii)Β in no event shall the receipt or consummation of the financing described in this SectionΒ 5.14(b) be deemed to be a condition to the consummation of the Offer, the Merger or any other transaction contemplated by this Agreement or by the CVR Agreement.
40
Β Β Β Β Β Β Β Β SectionΒ 5.15.Β Β Β Β Notices of Certain Events.Β Β Β Β Each of Parent and the Company shall promptly notify the other of:
Β Β Β Β Β Β Β Β (a)Β Β Β any notice or other communication received by that party from (i)Β any Person alleging that the consent of that Person is or may be required in connection with the transactions contemplated by this Agreement or by the CVR Agreement or (ii)Β subject to applicable law, court order and applicable privilege considerations, any party to the Litigation (as defined in the CVR Agreement) relating to the Litigation;
Β Β Β Β Β Β Β Β (b)Β Β Β any notice or other communication received by that party from any governmental or regulatory agency or authority in connection with the transactions contemplated by this Agreement or by the CVR Agreement;
Β Β Β Β Β Β Β Β (c)Β Β Β any actions, suits, claims, investigations or proceedings commenced or, to its knowledge, threatened against, relating to or involving or otherwise affecting the Company or any of its Subsidiaries that, if pending on the date of this Agreement, would have been required to have been disclosed pursuant to any of Sections 4.08, 4.10, 4.12, 4.13, 4.14, 4.15Β Β orΒ Β 4.16, as the case may be, or that relate to the consummation of the transactions contemplated by this Agreement.
Β Β Β Β Β Β Β Β (d)Β Β Β the occurrence or non-occurrence of any event or the discovery of any fact that would be reasonably expected to cause any representation or warranty of that party that is contained in this Agreement to be untrue or inaccurate such that the condition set forth in clauseΒ (c) of ExhibitΒ A hereto would at any time be unsatisfied on and as of any date after the date of this Agreement; and
Β Β Β Β Β Β Β Β (e)Β Β Β any failure of such party to comply with or satisfy in any material respect any covenant, condition or agreement to be complied with or satisfied by it under this Agreement or the CVR Agreement.
Β Β Β Β Β Β Β Β SectionΒ 5.16.Β Β Β Β CVR Agreement.Β Β Β Β (a)Β The parties hereto covenant and agree that immediately prior to the issuance of the first CVR to be issued under the CVR Agreement, they will, and will cause their respective Rights Agents (which Parent and the Company will appoint prior to such execution and delivery) to, execute and deliver the CVR Agreement substantially in the form attached hereto as ExhibitΒ B.
Β Β Β Β Β Β Β Β (b)Β Β Β Within 15Β days after the execution and delivery of the CVR Agreement, Parent and the Company will use all commercially reasonable efforts to cause the Rights Agents to (i)Β agree on the Independent Rights Agent (as defined in the CVR Agreement) and the compensation of such person, (ii)Β decide which Rights Agent will preside over the meetings of the Rights Agents and (iii)Β agree on all other provisions of the CVR Agreement that require prompt concurrence (including, without limitation, addresses for notice and the name of the tie-breaking accounting firm.)
Β Β Β Β Β Β Β Β (c)Β Β Β Parent and Merger Sub covenant and agree that, during the period from the date hereof to the Acceptance Date, neither they nor any of their respective Affiliates shall entertain or initiate any settlement discussions regarding the Litigation.
41
Β Β Β Β Β Β Β Β SectionΒ 5.17Β Β Β Β Commitment Letters; No Distributions by Parent.Β Β Β Β Neither Parent nor Merger Sub shall take any action to terminate either Commitment Letter or to amend or modify either Commitment Letter in any manner adverse to Parent, Merger Sub or the Company, without the prior written consent of each such Person. Furthermore, without limiting Parent's ability in any way to effect the Recapitalization (as defined in the Commitment Letter of Xxxxxxxxxx) on or after the Effective Time (except as expressly limited by the terms of the Commitment Letter of Xxxxxxxxxx) Parent shall not (i)Β declare, set aside or pay any dividend or distribution in respect of any shares of its capital stock or (ii)Β repurchase, redeem or otherwise acquire any shares of capital stock or other securities of, or other ownership interests in, Parent.
ARTICLE VI
CONDITIONS TO THE MERGER
Β Β Β Β Β Β Β Β SectionΒ 6.01.Β Β Β Β Conditions to the Obligations to Consummate the Merger.Β Β Β Β The respective obligations of the Company, Parent and Merger Sub to consummate the Merger are subject to the satisfaction on or prior to the Closing Date of the following conditions:
Β Β Β Β Β Β Β Β (a)Β Β Β Merger Sub shall have purchased shares of Company Common Stock pursuant to the Offer, except that this condition shall not be a condition to Parent's and Merger Sub's obligation to effect the Merger if Merger Sub shall have failed to purchase shares of Company Common Stock pursuant to the Offer in breach of (or as a result of Parent's breach of) this Agreement;
Β Β Β Β Β Β Β Β (b)Β Β Β this Agreement and the Merger shall have been approved and adopted by the requisite vote of the stockholders of the Company, if required by the DGCL;
Β Β Β Β Β Β Β Β (c)Β Β Β no law, rule or regulation or judgment, injunction, order or decree of a court or governmental agency or authority of competent jurisdiction shall be in effect which has the effect of making the Merger illegal or otherwise restraining or prohibiting the consummation of the Merger; and
Β Β Β Β Β Β Β Β (d)Β Β Β (A) any waiting period applicable to consummation of the Merger under the HSR Act or any Foreign Antitrust Laws shall have expired or been terminated and (B)Β any approvals required under Foreign Antitrust Laws before consummation of the Merger shall have been obtained.
ARTICLE VII
TERMINATION
Β Β Β Β Β Β Β Β SectionΒ 7.01.Β Β Β Β Termination.Β Β Β Β This Agreement may be terminated and the Offer and the Merger contemplated hereby may be abandoned at any time prior to the Effective Time (notwithstanding any approval of this Agreement by the stockholders of the Company):
42
Β Β Β Β Β Β Β Β (a)Β Β Β by mutual written consent of the Company and Parent (including, from and after the Acceptance Date, the Independent Director Approval contemplated by SectionΒ 1.03(c));
Β Β Β Β Β Β Β Β (b)Β Β Β prior to the Acceptance Date by Parent if the Company shall have breached in any material respect any of its obligations contained in this Agreement or if its representations and warranties shall not be true and correct, except for such failures to be true and correct that, individually and in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect, and which breach has not been or is incapable of being cured by the Company within thirty (30)Β days after the giving of written notice of such breach by Parent;
Β Β Β Β Β Β Β Β (c)Β Β Β prior to the Acceptance Date by the Company if Parent or Merger Sub shall have breached in any material respect any of its obligations to be performed by either of them under this Agreement, or if the representations and warranties of Parent and Merger Sub contained in this Agreement shall not be true and correct, except for such failures to be true and correct that, individually and in the aggregate, are not reasonably likely to have a material adverse effect on Parent, and which breach has not been or is incapable of being cured by Parent or Merger Sub, as applicable, within thirty (30)Β days after the giving of written notice of such breach by the Company;
Β Β Β Β Β Β Β Β (d)Β Β Β prior to the Acceptance Date by the Company if (i)Β the Board of Directors of the Company authorizes the Company, subject to complying with the terms of this Agreement, to enter into a binding written agreement concerning a transaction that constitutes a Superior Proposal and the Company gives Parent notice (which may be revoked by the Company by a subsequent notice to that effect) in writing that it intends to enter into such an agreement, specifying the material terms and conditions of such Superior Proposal and the identity of the Potential Acquiror, provided that the Board of Directors may only take those actions if it has determined, in good faith after consultation with its financial advisor and based on the advice of its outside counsel, that doing so is necessary in order for the directors to comply with their fiduciary duties under applicable law, (ii)Β Parent does not make, within three business days of receipt of the Company's written notification of its intention to enter into a binding agreement providing for the Superior Proposal, an offer that is at least as favorable from a financial point of view, to the stockholders of the Company as the Superior Proposal and (iii)Β the Company prior to or concurrently with such termination pays to Parent in immediately available funds the Termination Fee (as defined in SectionΒ 8.01(b));
Β Β Β Β Β Β Β Β (e)Β Β Β prior to the Acceptance Date by Parent, if (i)Β the Board of Directors of the Company shall have failed to recommend, or shall have withdrawn, adversely modified or adversely amended in any material respect its approval or recommendation of the Offer, the Merger or this Agreement to the Company's stockholders, it being understood that disclosure of the existence of and the material terms and conditions of any Acquisition Proposal that is not being recommended by the Board of Directors of the Company, shall not be considered to be a withdrawal, adverse modification or adverse amendment in any material respects of such approval or recommendation, or (ii)Β there shall have been a material breach of SectionΒ 5.03;
43
Β Β Β Β Β Β Β Β (f)Β Β Β Β by either Parent or the Company if (i)Β the Acceptance Date shall not have occurred on or before DecemberΒ 31, 2003; provided that the right to terminate this Agreement under this SectionΒ 7.01(f) shall not be available to any party whose failure to fulfill any obligation under this Agreement has been the cause of, or resulted in, the failure of the Acceptance Date to occur on or before such date or (ii)Β if there shall be any law or regulation or any governmental entity shall have issued an order, injunction or other decree or ruling or taken any other action permanently enjoining, restraining, making illegal or otherwise prohibiting the payment for the Company Common Stock pursuant to the Offer and/or Merger and that order, injunction, decree or ruling or other action shall have become final and nonappealable; or
Β Β Β Β Β Β Β Β (g)Β Β Β by the Company if Parent or Merger Sub shall have failed to commence the Offer in accordance with the SectionΒ 1.01; provided, however, that the Company may not terminate this Agreement pursuant to this SectionΒ 7.01(g) if such failure to have commenced the Offer shall have been caused by (i)Β the Company's failure to perform any of its obligations under this Agreement, (ii)Β facts or circumstances that constitute a breach of any representation or warranty of the Company under this Agreement or (iii)Β the occurrence of any of the events specified in any of paragraphs (a)Β through (g)Β of ExhibitΒ A.
Β Β Β Β Β Β Β Β The party desiring to terminate this Agreement pursuant to any clause of this SectionΒ 7.01 (other than pursuant to SectionΒ 7.01(a)) shall give notice of that termination to the other party.
ARTICLE VIII
MISCELLANEOUS
Β Β Β Β Β Β Β Β SectionΒ 8.01.Β Β Β Β Effect of Termination.Β Β Β Β (a)Β In the event of termination of this Agreement by either Parent and/or the Company prior to the Acceptance Date pursuant to the provisions of SectionΒ 7.01, this Agreement shall forthwith become void, and there shall be no liability or further obligation on the part of the Company, Parent, Merger Sub, their respective Affiliates or their respective officers or directors (except as set forth in any of this ArticleΒ VIII, in the second sentence of SectionΒ 5.04 and in SectionΒ 5.10, all of which shall survive the termination). Nothing in this SectionΒ 8.01 shall relieve any party from liability for any (i)Β willful or material breach of any covenant or agreement of such party contained in this Agreement or (ii)Β willful failure of that party to fulfill a condition to the performance of the obligations of the other party.
Β Β Β Β Β Β Β Β (b)Β Β Β In the event that this Agreement is terminated by Parent pursuant to SectionΒ 7.01(e)(ii) prior to the Company Meeting, and within 12Β months after any such termination the Company enters into a definitive agreement with respect to or consummates a transaction that constitutes an Acquisition Proposal (whether or not with the same Potential Acquiror with respect to which the Company committed a material breach of SectionΒ 5.03, then the Company shall promptly, but in no event later than two days after the date of entering into (or, if earlier, consummating) such agreement or transaction, as applicable, pay Parent a termination fee of $4,000,000 the ("Termination Fee") by wire transfer of same day funds.
44
Β Β Β Β Β Β Β Β (c)Β Β Β In the event that this Agreement is terminated by the Company pursuant to SectionΒ 7.01(d) or by Parent pursuant to SectionΒ 7.01(e)(i), the Company shall, in the case of termination by the Company, prior to or concurrently with such termination, and in the case of termination by Parent, promptly but in no event later than two days after the date of such termination, pay Parent the Termination Fee by wire transfer of same day funds.
Β Β Β Β Β Β Β Β (d)Β Β Β If this Agreement is terminated pursuant to SectionΒ 7.01(f)(i) and prior to any such termination:
Β Β Β Β Β Β Β Β Β Β (i)Β Β any Potential Acquiror shall have publicly announced an intention to make or actually makes an Acquisition Proposal (whether or not conditional) and, within 12Β months after any such termination, the Company or any of its Subsidiaries enters into a definitive agreement with respect to or consummates a transaction constituting an Acquisition Proposal (whether or not with the same Potential Acquiror), then the Company shall promptly, but in no event later than two days after the date of entering into (or, if earlier, consummating) that agreement or transaction, as applicable, pay Parent the Termination Fee by wire transfer of same day funds; or
Β Β Β Β Β Β Β Β Β (ii)Β Β any third party to the Litigation shall have publicly announced an intention to make or actually makes any proposal or offer with respect to any Settlement Decision (whether or not conditional) and, within 12Β months after any such termination, the Company or any of its Subsidiaries enters into a definitive agreement with respect to any Settlement Decision, then the Company shall, by wire transfer of same day funds, pay Parent the Termination Fee and also reimburse Parent for all reasonable and documented out-of-pocket expenses incurred by or on behalf of Parent in connection with the due diligence investigation of the Company and its subsidiaries and the negotiation and performance of this Agreement and the CVR Agreement and the taking of all actions contemplated by or in connection with any such agreement up to a maximum possible amount of such expenses of $2,000,000. The Company shall pay that Termination Fee promptly, but any event within two days after the date of entering into any such agreement, and it shall so reimburse Parent promptly (but in any event within three business days) after being invoiced therefor.
Β Β Β Β Β Β Β Β (e)Β Β Β The Company acknowledges that the agreements contained in this SectionΒ 8.01 are an integral part of the transactions contemplated by this Agreement and that, without these agreements, Parent and Merger Sub would not enter into this Agreement or the CVR Agreement. Accordingly, if the Company fails promptly to pay any Termination Fee (or reimburse any expenses) due to Parent pursuant to this SectionΒ 8.01, it shall also pay any costs and expenses incurred by or on behalf of Parent or Merger Sub in connection with any legal action(s) to enforce this SectionΒ 8.01.
Β Β Β Β Β Β Β Β SectionΒ 8.02.Β Β Β Β Non-Survival of Representations and Warranties.Β Β Β Β No representations or warranties in this Agreement or in any instrument delivered pursuant to this Agreement shall survive the Acceptance Date, with respect to representations and warranties of the Company, or the Effective Time with respect to representations and warranties of Parent and Merger Sub. This SectionΒ 8.02 shall not limit any covenant or agreement of the parties which by its terms contemplates performance after such time.
45
Β Β Β Β Β Β Β Β SectionΒ 8.03.Β Β Β Β Notices.Β Β Β Β All notices and other communications hereunder shall be in writing and shall be deemed given if delivered personally, mailed by registered or certified mail (return receipt requested) or sent via facsimile to the parties at the following addresses (or at such other address for a party as shall be specified by like notice):
If to Parent or Merger Sub, to:
Gingko
Corporation
c/o Symphony Technology Group
0000 Xxxxxxx Xxxxxx
0xx Xxxxx
Xxxx Xxxx, Xxxxxxxxxx 00000
Attention: Managing Partner
Facsimile: (000)Β 000-0000
with copies to:
Symphony
Technology Group
0000 Xxxxxxx Xxxxxx
0xx Xxxxx
Xxxx Xxxx, Xxxxxxxxxx 00000
Attention: Managing Partner
Facsimile: (000)Β 000-0000
Xxxxxxxxxx
Capital Partners, LLC
00000 Xxxxx Xxxxxx Xxxxxxxxx, Xxxxx 000
Xxx Xxxxxxx, Xxxxxxxxxx 00000
Attention: Xxxxxxx Xxxxxxxxxx
Facsimile: (000)Β 000-0000
Xxxxx
XxxxΒ & Xxxxxxxx
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Attention: Xxxx Xxxxxx
Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Xxxx X. Xxxxxxx
Facsimile: (000)Β 000-0000
Xxxxxx
XxxxΒ & Xxxxxxxx LLP
000 Xxxxx Xxxxx Xxxxxx
Xxx Xxxxxxx, XX 00000
Attention: Xxxxxxxx Xxxxxxxxxx
Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Β Xxxxx El-Xxxxx
Facsimile: (000)Β 000-0000
If to the Company, to:
46
Information
Resources,Β Inc.
000 Xxxxx Xxxxxxx Xxxxxx
Xxxxxxx, Xxxxxxxx 00000
Attention: General Counsel
Facsimile: (000)Β 000-0000
with a copy to:
WinstonΒ &
Xxxxxx
00 X. Xxxxxx Xxxxx
Xxxxxxx, Xxxxxxxx 00000
Attention: Xxxxxxxx X. Xxxxx
Facsimile: (000)Β 000-0000
or such other address or facsimile number as such party may hereafter specify for the purpose by notice to the other parties hereto. All such notices, requests and other communications shall be deemed received on the date of receipt by the recipient thereof if received prior to 5:00Β p.m. in the place of receipt and such day is a business day in the place of receipt. Otherwise, any such notice, request or communication shall be deemed not to have been received until the next succeeding business day in the place of receipt.
Β Β Β Β Β Β Β Β SectionΒ 8.04.Β Β Β Β Interpretation.Β Β Β Β The headings contained in this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement. In this Agreement, unless a contrary intention appears, (i)Β the words "herein," "hereof" and "hereunder" and other words of similar import refer to this Agreement as a whole and not to any particular Article, Section or other subdivision and (ii)Β reference to any Article or Section means such Article or Section hereof. No provision of this Agreement shall be interpreted or construed against any party hereto solely because such party or its legal representative drafted such provision. Whenever the words "include," "includes" or "including" are used in this Agreement, they shall be deemed to be followed by the words "without limitation."
Β Β Β Β Β Β Β Β SectionΒ 8.05.Β Β Β Β Miscellaneous.Β Β Β Β This Agreement (including the documents and instruments referred to herein) shall not be assigned by operation of law or otherwise except that (a)Β Merger Sub may assign its rights and obligations under this Agreement to any other wholly-owned Subsidiary of Parent and (b)Β with the prior written consent of the Company (which shall not be unreasonably withheld or delayed), Parent may assign its rights and obligations under this Agreement to any other Person that is an Affiliate of Symphony and Xxxxxxxxxx; provided that, in connection with any such assignment, Parent also assigns to the assignee Parent's rights and obligations under the Commitment Letters and the issuers of such Commitment Letters shall have consented in writing to such assignment. THIS AGREEMENT SHALL BE GOVERNED IN ALL RESPECTS, INCLUDING VALIDITY, INTERPRETATION AND EFFECT, BY THE LAWS OF THE STATE OF DELAWARE APPLICABLE TO CONTRACTS EXECUTED AND TO BE PERFORMED WHOLLY WITHIN SUCH STATE WITHOUT GIVING EFFECT TO THE CHOICE OF LAW PRINCIPLES OF SUCH STATE.
47
Β Β Β Β Β Β Β Β SectionΒ 8.06.Β Β Β Β Counterparts.Β Β Β Β This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original, but all of which shall constitute one and the same agreement.
Β Β Β Β Β Β Β Β SectionΒ 8.07.Β Β Β Β Amendments; Extensions.Β Β Β Β (a)Β This Agreement may be amended by the parties hereto, by action taken or authorized by their respective Boards of Directors at any time; provided that, (i)Β after the Acceptance Date, (A)Β no amendment shall be made which decreases the Merger Consideration and (B)Β any such amendment will require the Independent Director Approval contemplated by SectionΒ 1.03 and (ii)Β after the Company Stockholder Approval has been obtained (if required by the DGCL), there shall be made no amendment that by law requires further approval by stockholders of the Company without the further approval of such stockholders. This Agreement may not be amended or waived except by an instrument in writing signed (in the case of an amendment) by each of the parties hereto or (in the case of a waiver) by the party(ies) against whom the waiver is to be effective.
Β Β Β Β Β Β Β Β (b)Β Β Β At any time prior to the Effective Time, by action taken or authorized by (i)Β the respective Boards of Directors of the parties hereto (which after the Acceptance Date will require, with respect to the Company, the Independent Director Approval contemplated by SectionΒ 1.03), the parties hereto may, to the extent legally allowed, extend the time for the performance of any of the obligations or other acts of the other parties hereto and (ii)Β its Board of Directors (which after the Acceptance Date will require, with respect to the Company, the Independent Director Approval contemplated by SectionΒ 1.03), any party(ies) hereto may waive (A)Β any inaccuracies in the representations and warranties of any other party(ies) contained herein or in any document delivered pursuant hereto or (B)Β compliance by any other party(ies) with any of the covenants or agreements of such other party(ies) or any conditions contained in this Agreement (including, for the sake of clarity, ExhibitΒ A hereto) to the performance of any of its or their obligations hereunder; provided that after the Company Stockholder Approval has been obtained (if required by the DGCL), there shall be made no waiver that by law requires further approval by stockholders of the Company without the further approval of such stockholders. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in a written instrument signed on behalf of such party. The failure or delay of any party to this Agreement to assert any of its rights under this Agreement or otherwise shall not constitute a waiver of those rights. Additionally, no single or partial exercise of any right shall preclude any other or further exercise of that right or the exercise of any other right, power or privilege. The rights and remedies provided in this Agreement shall be cumulative and not exclusive of any rights or remedies provided by law.
Β Β Β Β Β Β Β Β SectionΒ 8.08.Β Β Β Β Entire Agreement.Β Β Β Β This Agreement, the CVR Agreement and the Confidentiality Agreement constitute the entire agreement between the parties with respect to the subject matter hereof and thereof and supersede all prior agreements, understandings and negotiations, both written and oral, between the parties with respect to the subject matter of this Agreement. No representation, inducement, promise, understanding, condition or warranty not set forth herein has been made or relied upon by either party hereto. Neither this Agreement nor any provision hereof is intended to confer upon any Person (other than the parties hereto) any rights or remedies hereunder except for the provisions of SectionΒ 5.12, which are intended for the benefit of the Indemnified Parties.
48
Β Β Β Β Β Β Β Β SectionΒ 8.09.Β Β Β Β Severability.Β Β Β Β If any term or other provision of this Agreement is held by a court or other Governmental Agency of competent jurisdiction to be invalid, illegal or unenforceable, all other provisions of this Agreement shall remain in full force and effect so long as the economic or legal substance of the transactions contemplated hereby is not affected in any manner materially adverse to any party. Upon such a determination, the parties shall negotiate in good faith to modify this Agreement so as to effect the original intent of the parties as closely as possible in an acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the fullest extent possible.
Β Β Β Β Β Β Β Β SectionΒ 8.10.Β Β Β Β Specific Performance; Limitation on Damages.Β Β Β Β The parties hereto agree that irreparable damage would occur in the event any of the provisions of this Agreement were not to be performed in accordance with the terms hereof and that the parties shall be entitled to specific performance of the terms hereof in addition to any other remedies at law or in equity. IN NO EVENT SHALL ANY PARTY BE LIABLE IN RESPECT OF THIS AGREEMENT FOR ANY PUNITIVE OR EXEMPLARY DAMAGES OR ANY CONSEQUENTIAL DAMAGES, OTHER THAN THOSE CONSEQUENTIAL DAMAGES THAT WERE REASONABLY FORESEEABLE AS OF THE DATE OF THIS AGREEMENT (BUT EXCLUDING, IN ALL CASES, DAMAGES IN THE FORM OF GOODWILL, LOST FUTURE PROFITS AND LOST CUSTOMERS).
Β Β Β Β Β Β Β Β SectionΒ 8.11.Β Β Β Β No Admission.Β Β Β Β Nothing herein, including SectionΒ 4.11, shall be deemed an admission by the Company, in any action or proceeding by or on behalf of a third-party, that such third-party is not in breach or violation of, or in default in, the performance or observance of any term or provision of any contract.
Β Β Β Β Β Β Β Β SectionΒ 8.12.Β Β Β Β Jurisdiction.Β Β Β Β The parties hereto agree that any suit, action or proceeding seeking to enforce any provision of, or based on any matter arising out of or in connection with, this Agreement, the Confidentiality Agreement or the CVR Agreement or the transactions contemplated hereby or thereby shall be brought in any federal court located in the State of Delaware or any Delaware state court, and each of the parties hereby irrevocably consents to the exclusive jurisdiction of those courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection that it may now or hereafter have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on such party as provided in SectionΒ 8.03 shall be deemed effective service of process on such party.
Β Β Β Β Β Β Β Β SectionΒ 8.13.Β Β Β Β WAIVER OF JURY TRIAL.Β Β Β Β EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.
49
Β Β Β Β Β Β Β Β IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.
Β | Β | INFORMATION RESOURCES,Β INC. | ||||
Β |
Β |
By: |
Β |
/s/Β Β XXXXXX XXXXXXXΒ Β Β Β Β Β |
||
Β | Β | Β | Β | Name: | Β | Xxxxxx Xxxxxxx |
Β | Β | Β | Β | Title: | Β | Chief Executive Officer |
Β |
Β |
GINGKO CORPORATION |
||||
Β |
Β |
By: |
Β |
/s/Β Β XXXXXXX XXXXXXXXΒ Β Β Β Β Β |
||
Β | Β | Β | Β | Name: | Β | Xxxxxxx Xxxxxxxx |
Β | Β | Β | Β | Title: | Β | Executive Vice President |
Β |
Β |
GINGKO ACQUISITION CORP. |
||||
Β |
Β |
By: |
Β |
/s/Β Β XXXXXXX XXXXXXXXΒ Β Β Β Β Β |
||
Β | Β | Β | Β | Name: | Β | Xxxxxxx Xxxxxxxx |
Β | Β | Β | Β | Title: | Β | Executive Vice President |
EXHIBITΒ A
Β Β Β Β Β Β Β Β Notwithstanding any other term of the Offer or the Agreement, Merger Sub shall not be required to accept for payment or, subject to any applicable rules and regulations of the SEC, including RuleΒ 14e-l(c) under the Exchange Act (relating to Merger Sub's obligation to pay for or return tendered shares of Company Common Stock promptly after the termination or withdrawal of the Offer), to pay for any shares of Company Common Stock tendered pursuant to the Offer, unless (i)Β there shall have been validly tendered and not withdrawn prior to the expiration of the Offer that number of shares of Company Common Stock which, when added together with all other shares of Company Common Stock owned by Parent and its subsidiaries, would represent at least a majority of the outstanding Company Common Stock (determined on a fully diluted basis for all outstanding stock options and any other rights (other than Company Rights, if such Company Rights are not at such time exercisable) to acquire Company Common Stock outstanding on the date of purchase) (the "Minimum Tender Condition"), (ii)Β any requisite waiting period under the HSR Act applicable to the purchase of shares of Company Common Stock pursuant to the Offer or to the Merger shall have been terminated or shall have expired, and (iii)Β the applicable waiting periods under the Foreign Antitrust Laws shall have been terminated or shall have expired. Furthermore, notwithstanding any other term of the Offer or this Agreement, Merger Sub shall not be required to accept for payment or, subject as aforesaid, to pay for any shares of Company Common Stock not theretofore accepted for payment or paid for, if, immediately prior to the acceptance for payment of shares of Company Common Stock pursuant to the Offer, any of the following conditions exists:
Β Β Β Β Β Β Β Β (a)Β Β Β there shall have been entered, enforced or issued by any Governmental Agency of competent jurisdiction any judgment, order, injunction or decree that (i)Β makes illegal, restrains or prohibits, or imposes any material limitation on, the making of the Offer, the acceptance for payment of, or payment for, any shares of Company Common Stock by Parent or Merger Sub, or the consummation of the Merger, (ii)Β prohibits, or imposes any material limitation on, the ownership, control or operation by Parent or any of its Subsidiaries of the Company or any of its material Subsidiaries or assets; or (iii)Β renders the CVR Agreement unenforceable in any material respect;
Β Β Β Β Β Β Β Β (b)Β Β Β there shall have been any statute, rule, regulation, legislation or interpretation enacted, enforced, promulgated, amended or issued by any Governmental Agency or deemed by any Governmental Agency applicable to (i)Β Parent, the Company or any subsidiary or Affiliate of Parent or the Company or (ii)Β any transaction contemplated by this Agreement or by the CVR Agreement, other than the HSR Act and any Foreign Antitrust Laws which would reasonably be expected to result, directly or indirectly, in any of the consequences referred to in any of clauses (i), (ii)Β or (iii)Β of paragraphΒ (a) above;
Β Β Β Β Β Β Β Β (c)Β Β Β the representations and warranties of the Company contained in this Agreement (excluding, for the purpose of this condition only, any qualifications contained therein with respect to materiality or Company Material Adverse Effect) shall not be true and
correct as of such time (as if made at and as of such time), except for such failures to be true and correct that, whether individually or in the aggregate, would not reasonably be expected to have a Company Material Adverse Effect;
Β Β Β Β Β Β Β Β (d)Β Β Β the Company shall have failed to perform in any material respect any material obligation required to be performed by it at or prior to such time under this Agreement;
Β Β Β Β Β Β Β Β (e)Β Β Β no change or development shall have occurred in the business, financial condition or results of operations of the Company or any of its Subsidiaries, and no fact or circumstance that occurred or arose after DecemberΒ 31, 2002 shall become known to Parent for the first time after the date of this Agreement, that, whether individually or in the aggregate, would reasonably be expected to have a Company Material Adverse Effect; or
Β Β Β Β Β Β Β Β (f)Β Β Β Β this Agreement shall have been terminated in accordance with its terms.
Β Β Β Β Β Β Β Β The foregoing conditions are for the sole benefit of Merger Sub and Parent and may be asserted by Merger Sub or Parent regardless of the circumstances giving rise to such condition or may be waived by Merger Sub and Parent in whole or in part at any time and from time to time in their reasonable discretion. The failure by Parent, Merger Sub or any other affiliate of Parent at any time to exercise any of the foregoing rights shall not be deemed a waiver of any such right; the waiver of any such right with respect to particular facts and circumstances shall not be deemed a waiver with respect to any other facts and circumstances, and each such right shall be deemed an ongoing right that may be asserted at any time and from time to time.
Β Β Β Β Β Β Β Β Any capitalized term that is used, but not defined, in this ExhibitΒ A has the meaning that is assigned to that term in the Agreement to which this Exhibit is attached.
EXHIBITΒ B
FORM OF CONTINGENT VALUE RIGHTS AGREEMENT
TABLE OF CONTENTS
AGREEMENT AND PLAN OF MERGER
ARTICLE IV REPRESENTATIONS AND WARRANTIES OF THE COMPANY
CONDITIONS OF THE OFFER
FORM OF CONTINGENT VALUE RIGHTS AGREEMENT